Action of Tyrosyl DNA Phosphodiesterase on 3\u27-Phosphoglycolate Terminated DNA Strand Breaks by Tatavarthi, Haritha
Virginia Commonwealth University
VCU Scholars Compass
Theses and Dissertations Graduate School
2006
Action of Tyrosyl DNA Phosphodiesterase on 3'-
Phosphoglycolate Terminated DNA Strand Breaks
Haritha Tatavarthi
Virginia Commonwealth University
Follow this and additional works at: http://scholarscompass.vcu.edu/etd
Part of the Medical Pharmacology Commons
© The Author
This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses
and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/etd/1140
ACTION OF TYROSYL DNA PHOSPHODIESTERASE ON 3'-PHOSPHO 
GLYCOLATE TERMINATED DNA STRAND BREAKS 
A thesis submitted in partial fulfillment of the requirements for the Master Degree of 
Science at Virginia Commonwealth University. 
HARITHA TATAVARTHI 
M.S. RAMAIAH COLLEGE OF PHARMACY, INDIA, 2000 
Director: LAWRENCE F. POVIRK 
PROFESSOR, DEPARTMENT OF PHARMACOLOGY AND TOXICOLOGY 
Virginia Commonwealth University 
Richmond, Virginia 
May 2006 
O HARITHA TATAVARTHI 2006 
All Rights Reserved 
Table of Contents 
List of Figures ...................................................................... 
.............................................................. List of Abbreviations 
Abstract ............................................................................. 
Introduction ....................................................................... 
.................................................. Consequences of DSBs 
........................................... DSB detection and signaling 
.................................................... DSB repair pathways 
Homologous recombination repair pathway ......................... 
Non-Homologous end-joining pathway .............................. 
Structural and biochemical properties of end-joining proteins .... 
.................................................. Ku heterodimer 
...................................................... DNA-PKCS 
...................................... XRCC41 DNA Ligase IV 
............................................. Oxidative Stress and DSBs 
...................................... Tyrosyl DNA phosphodiesterase 
Tdpl is member of the phospholipase D superfamily ............. 
.......................................... Substrate specificity of Tdpl 
Role of Tdpl in SSB repair .................................. 
Proposed mechanism of action of Tdpl ............................. 
Spinicerebellar ataxia with axonal neuropathy ............ 
Other roles of Tdpl ........................................... 
....................................................... Methods and Materials 
Polyacrylarnide gel electrophoresis .................................. 
............................... High-pressure liquid chromatography 
Whole-cell extract preparation from human 
.................................... lymphoblastoid cells (GM0058B) 
Purification of DNA from non-competent cells using QIAamp 
............................................................ DNA Minikit 
Transfer of pure DNA into XLl -Blue competent cells ............ 
Recombinant hTdpl was purified using HiTrap nickel chelating 
.................................................................. columns 
Cloning of Tdpl gene into pFLAG-CMV2 human expression 
... 
Vll l  
... 
Xl l l  
vector. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 3 
Transient transfection of FLAG-Tdpl and Untagged-Tdpl into 293B 
. . 
embryonic kidney cells.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 
Purification of recombinant Tdp 1 protein by pull-down with Flag 
beads and elution with Flag Peptide (by detergent). . . . . . . . . . . . . . . . . . . . . . . . 35 
Purification of recombinant Tdpl protein by Pull-down with Flag 
beads and elution with Flag Peptide (by dounce homogenization). . . . . . 36 
Whole-cell extract preparation from lymphoblastoid cells obtained 
from SCANl patients (JRL1, JRL3, JRL4), from unaffected relatives 
(JRL2, JRL5) and fiom known heterozygous carriers (JRL6, JRL7). . . . 37 
Gel Filtration chromatography and end-processing assays with 
GM005 5 8B fractions.. . . . . . . . . . .  . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 7 
End-processing assays of a double-stranded substrate with a 3'-PG 
overhang by Ku, DNA-PK and XRCC4-ligase IV.. . . . . . . . . . . . . . . . . . . . . . . .. 39 
Western Blotting.. . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . .. . . . . . ... 40 
Results .................................................................................... 43 
Tyrosyl-DNAphosphodiesterase (Tdpl) is capable of removing 
glycolate fkom 3'-PG overhangs.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... 
No evidence of multiple forms of the enzyme separable by the 
sephacryl column. .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Processing efficiency of s c ~ d p l  is affected by various factors.. . . . . . . . ... 
Recombinant human Tdpl shows relatively lower 3'-PG 
removal activity than partially purified native hTdpl . . . . . . . . . . . . . . . . . . . . . .. 
No evidence of the Flag peptide having any effect on the 
. . 
specificity of the enzyme.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Better recovery of Tdpl activity by NP-40 detergent lysis 
than by dounce homogenization.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Relative processing efficiency of FLAG-hTdpl cloned into 
an adenovirus was -1 00-fold.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Extracts of SCANl cells with mutant Tdpl are deficient in 
PG-processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
No evidence for the presence of other M ~ + *  -dependent 
PG-processing enzymes.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Processing of the single-strand PG terminated oligomer by 
human FLAG-Tdpl is independent of cofactor requirement.. . . . . . . . . . . 
Tdpl associates with XRCC 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
XRCC 1 -complementation enhances Tdpl -activity.. . . . . . . . . . . . . . . . . . . . .. 
Presence of Tdpl protein in mitochondrial extracts.. . . . . . . . . . . . . .. . . . . . . 
Mitochondria1 extracts show similar PG-processing efficiency 
as whole-cell extracts.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Processing efficiencies of JRL 5 (wild-type Tdpl) and JRL 3 
(mutant Tdp 1) mitochondria1 extracts.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Processing of a 3'-PG oligomer is partially inhibited by Ku.. . . . . . . . . . . 
Processing of a double-stranded substrate with 3'-PG overhang 
is partially inhibited by Ku.. .............................................. 108 
Processing of the double-stranded substrate with 3'-PG overhang 
is partially inhibited by Ku-DNA-PK and 
Ku-DNA-PK-XRCC4lligase IV complexes.. ........................... 1 13 
Inhibition of DNA-PK autophosphorylation does not show a 
marked inhibition on Tdpl activity.. ..................................... 1 13 
Discussion.. .......................................................................... 128 
List of References.. ................................................................ 147 
Vita.. .................................................................................. 159 
List of Figures 
Figure Page 
1. 3'-PG (.) and 3'-phosphotyrosine (p-Tyr) substrates.. . . . . . . . . 44 
2. Conversion of 3'-phosphotyrosine termini to 3'-phosphate 
termini by native hTdp 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 
3. Conversion of 3'-PG termini to 3'-phosphate termini by 
native hTdp 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 
4. Relative efficiency of native end-processing activities.. . . . . 5 1 
5. Relative efficiencies of native end-processing activities.. ... 53 
6. Relative end-processing efficiencies of recombinant 
scTdp1.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57 
7. Relative end-processing efficiency of recombinant hTdp 1 .. 60 
8. The PET-1 5b E. coli vector; the source for His-tagged 
Tdpl gene ... .. . . . . .... . ... . ... . . . .. ... . .. . .. . .. .... . .. .. . .. . ... . ... 63 
9a. The pFLAG-CMV2 human -expression vector used for 
cloning Tdpl gene.. . .. .. .... . .. .... ... .. . ... . .... . . .. . .. .. . . .. . . . 65 
9b. Protocol for cloning ... . . . . . . . . . .. . . .. . . . .. . . . . . . . . . . . . . . . . . . . . . ... 67 
10. The pCMV-Tag1 human -expression vector used for 
cloning Tdpl gene. .. .. . ... . . .... ..... . .... . . ... .. .. . . ... .. .... . ... 68 
lla,  b. Protein gel using silver staining.. . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . .. 70 
l lc.  Western Blot analysis of whole-cell and purified extracts.. . . 72 
12. Relative end-processing efficiencies of FLAG-hTdpl and 
untagged hTdp 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75 
13. To compare the end-processing efficiencies of FLAG-hTdpl 
purified via dounce homogenization vs. FLAG-hTdp 1 
purified using 0.5% NP-40.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77 
* 
vii 
14a, b. Relative end-processing efficiency of FLAG-hTdpl cloned 
into an adenovirus.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 80 
15a, b. Relative end-processing efficiencies of SCANl whole-cell 
extracts (JRL 1-7). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83 
1%. Effect of addition of JRLl whole-cell extract to purified 
FLAG-tagged hTdp 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85 
16. No evidence for the presence of other M ~ + *  -dependent 
PG-processing enzymes.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 
17. ~ f f e c t  of 5 m~ m2 on h ~ d ~ l  activity.. . . . . . . . . . . , . . . . . . . . . . . . . . 90 
18a. Tdpl associates with XRCCl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93 
18b, c. Effect of XRCCl on FLAG-hTdpl activity.. . . . . . . . . . . . . . . . . . . . .. 96 
18d. A western blot analysis to check for the presence of Ku 
in irnmunoprecipitated hTdpl extracts.. . . . . . . . . . . . . . . . . . . . . . . . . . .. 98 
19. Western Blot analysis of whole-cell and mitochondria1 
extracts derived fromGM13 10 normal human fibroblasts 
and SCANl cells.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101 
20. Relative end-processing efficiencies of whole-cell vs. 
mitochondria1 extracts derived from GM13 10 
normal human fibroblasts. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 103 
21. Relative end-processing eficiencies of JRL 3 and 5 
mitochondria1 extracts.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106 
22. Processing of a 3'-PG oligomer by Ku derived from 
placental tissue.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109 
23. Processing of 3'-PG and 3'-phosphotyrosine oligomers 
by hTdpl in the presence of recombinant Ku.. . . . . . . . . . . . . . . . . . . . 11 1 
24a,b. Effect of different dilutions of Ku on FLAG-hTdpl activity.. . . 1 14 
24c. Effect of different concentrations of truncated Ku on 
FLAG-hTdp 1 activity.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 6 
25. Effect of different dilutions of Ku-DNA-PK complex on 
FLAG-hTdpl activity.. . , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , . . . . . . . . . 1 18 
... 
Vll l  
26. Effect of different dilutions of Ku-DNA-PK-XRCC4Jligase 
........................... IV complex on FLAG-hTdpl activity.. 12 1 
27. Effect of inhibition of autophosphorylation of DNA-PK on 
. . hTdpl activity.. ....................................................... 125 
- -  4 
... 
Vll l  
Ab 
ADP 
AP 
" A  
APE 
AT 
ATM 
ATP 
ATR 
bleo 
bp 
BSA 
" C  
cDNA 
CHO 
CS 
C-T 
DMSO 
DNA 
DNA-PK 
List of Abbreviations 
antibody 
adenosine diphosphate 
abasic, apyrimidinic, apurinic 
angstrom 
AP endonuclease 
ataxia telangiectasia 
ataxia telangiectasia mutated 
adenosine triphosphate 
ataxia telangiectasia related 
bleomycin 
base pair 
bovine serum albumin 
degree centigrade 
complementary DNA 
Chinese hamster ovary 
catalytic subunit 
carboxy terminal 
dimethyl sulfoxide 
deoxyribonucleic acid 
DNA dependent protein kinase 
DNA pol 
ds 
DSBs 
DTT 
E. coli 
EDTA 
EJ 
EMSA 
FCS 
Fmol 
HPLC 
HRR 
IC50 
DNA polymerase 
deoxyribonuclease 
deoxynucleotide triphosphate 
double stranded 
double strand breaks 
dithiothreitol 
Escherichia coli 
disodium ethylenediarninetetraacetate 
end joining 
electro mobility shift assay 
fetal calf serum 
femtomole 
high pressure liquid chromatography 
homologous recombination repair 
dose at which drug produces fifty percent inhibition 
imrnunoprecipitation 
ionizing radiation 
kilobyte 
potassium chloride 
kilo Dalton 
knock out 
magnesium 
manganese 
mol 
Pg 
ell 
PM 
MilliQ 
rnL 
mM 
Mr 
NAD 
NBS 
ng 
nm 
nM 
N-T 
OH 
% 
PAGE 
PARP 
PCR 
PBS 
PG 
PI 
PIK 
mole 
microgram 
microlitre 
micromolar 
deionized, distilled 
milliliter 
millimolar 
molecular weight 
nicotinamide adenosine syndrome 
nijmegan breakage syndrome 
nanogram 
nanometer 
nanomolar 
amino terminal 
hy droxyl 
percentage 
polyacrylamide gel electrophoresis 
poly ADP-ribose polymerase 
polymerase chain reaction 
phosphate buffered saline 
phosphor glycolate 
phosphatidyl inositol 
phosphatidyl inositol kinase 
PLD 
PNKP 
PO4 
REC 
RNA 
rpm 
RPMI 
Sc 
Scid 
SDS 
NaCl 
SS 
SV 40 
TBE 
TBS 
Tdp 1 
TEA 
TEMED 
Tris 
UV 
V(D)J 
WE3 
WS 
phospholipase D 
polynucleotide kinase phosphatase 
phosphate 
recombination 
ribonucleic acid 
rotations per minute 
Rosewell Park Institute medium 
Saccharomyces cerevisiae 
severe combined immunodeficient 
sodium dodecyl sulfate 
sodium chloride 
single strand 
simian virus 40 
Tris HCltBoratef EDTA 
Tris buffered saline 
Tyrosyl DNA phosphodiesterase 
triethy lamine 
N,N,N',N'-tetramethylethylene 
tris(hydroxymethy1)arninomethane 
ultra violet 
variable, (diversity), joining 
western blot 
Werner syndrome 
WRN 
wt 
XRCC 
xrs 
Werner syndrome protein 
wild type 
X-Ray cross complementation 
X-Ray sensitive 
. -.- 
xii 
Abstract 
- - -- 
... 
Xlll  
ACTION OF TYROSYL DNA PHOSPHODIESTERASE ON 3'- 
PHOSPHOGLYCOLATE TERMINATED DNA STRAND BREAKS 
Haritha Tatavarthi, MS 
A thesis submitted in partial fulfillment of the requirements for the Masters Degree of 
Science at Virginia Commonwealth University. 
Virginia Commonwealth University, 2006 
Major Director: Lawrence F. Povirk, Ph. D. 
Professor, Department of Pharmacology and Toxicology 
Free radical-mediated DNA double strand breaks (DSBs) are induced either 
directly by ionizing radiation or by certain chemicals like bleomycin. These breaks are 
terminated by 3'-PG (P04CH2C00-) or 3'-phosphate groups formed as a result of 
fragmentation of deoxyribose. 
To study the nature of repair of these 3'-blocked breaks, we constructed substrates 
mimicking fiee-radical induced DSBs. Human and yeast tyrosyl DNA-phosphodiesterase 
(Tdpl) efficiently processed substrates with 3'-PGs, in either the presence or absence of 
magnesium, to give a 3'-phosphate. Gel filtration chromatography and western blotting 
c o d m e d  that the putative enzyme in human extracts that efficiently processed PG was 
indeed tyrosyl DNA-phosphodiesterase. When recombinant hTdpl was purified using 
HiTrap nickel chelating columns and its PG processing activity compared to that of 
partially purified native enzyme (from lyrnphoblastoid whole-cell extracts using 
Sephacryl S-300 gel filtration columns), we found that the recombinant enzyme had 
xiv 
lesser 3'-PG removal activity than the partially purified native enzyme. On cloning 
recombinant FLAG-tagged hTdpl into human expression vectors, we observed that the 
FLAG epitope tag did not show any evidence of affecting the specificity of the enzyme. 
Due to the many differences between bacterial and human cells, we cloned recombinant 
FLAG-tagged hTdpl into U-87 cells (adenovirus infected glioma cell) and this 
recombinant enzyme showed the same specificity toward PG substrates as when prepared 
from bacteria. End-processing assays using the NHEJ proteins- Ku, DNA-PK and 
XRCC41Ligase N- alone or in combination showed an inhibition of hTdpl activity on 3'- 
overhangs. In nuclear extracts, hTdp 1 association with XRCC 1, a single-strand repair 
protein, showed to increase the PG-processing activity of Tdpl up to 4 times. Whole-cell 
extracts containing mutant Tdpl derived from patients suffering from spinocerebellar 
axonal neuropathy (SCAN1) were found to be deficient in PG-processing. Addition of 
JRLl whole-cell extract (SCAN1 extract containing mutant Tdpl) to purified FLAG- 
tagged hTdpl showed to decrease the phosphotyrosyl processing and increase the PG- 
processing of FLAG-tagged hTdpl suggesting that there must be other factors in the 
extract that affect the enzyme activity. 
Experiments carried out to check for the presence of Tdpl in mitochondrial extracts 
obtained fromGM13 10 normal human fibroblasts as well as in SCANl (JRL) 
rnitochondrial extracts, showed that mitochondrial extracts contained Tdpl at a 
concentration comparable to whole-cell extracts. Our results also showed that 
mitochondrial extracts fiom the SCANl cell-line, JRL3 (containing mutant Tdpl), lacked 
detectable Tdpl activity suggesting that all PG-processing activity in mitochondria may 
be attributable to Tdpl. 
Introduction 
The field of cancer research is ever expanding and seems to be of pivotal 
importance because man has known cancer ever since the dawn of civilization. With 
increased life span of individuals, the likelihood of surviving to an age of high 
susceptibility to cancer is ever increasing, and statistically at least one in three people 
develop cancer. One in four men and one in five women die fiom it. The field of 
molecular biology has opened doors to genetic analysis of normal and tumor cells and 
allowed us to delve into previously unapproachable questions about the molecular 
mechanisms behind the development of cancer. It is these developments as well as the 
quest for finding a cause and cure for the disease that has given cancer research so much 
importance and attention. 
Somatic mutations are the most common cause of development of cancer. 
Alterations as small as single base substitutions in specific genes can cause dramatic 
increases in the incidence of certain malignancies, for example colon cancer (Vogelstein 
and Kinzler, 1993). However it is known that cancer is a multi-step process involving an 
array of genetic alterations that come together to cause disruption of various cellular 
functions, ultimately leading to the development of cancer. With as many as 10,000 DNA 
lesions occurring in a metabolically active mammalian cell per day, highly discriminatory 
and efficient DNA repair mechanisms have developed for its preservation (Lindahl, 
1993). One of the most detrimental types of DNA damage is DNA double strand breaks 
(DSBs) because they can directly disrupt the normal cellular function and survival. 
Endogenous sources of DNA DSBs include disruption of DNA replication, as well as free 
radicals from oxidative metabolism (Giloni et al., 198 1, Hutchinson, 1985). Among DNA 
damaging agents, the most significant source of DSBs is ionizing radiation (IR) such as 
gamma, neutron, alpha, proton and X-radiation. DSBs of similar structure are produced 
by radiomimetics such as bleomycin, neocarzinostatin, calicheamicin and esperamicin. 
Bleomycin and enediyne antibiotics are called radiomimetic because their effects on cells 
are similar to those caused by radiation. The formation of ionizing radiation-induced DSB 
occurs mostly through excitation of a water molecule followed by its ionization into 
hydrogen and hydroxyl radicals in a process also known as radiolysis of water. 
1) excitation via IR: H20* H20* 
2) ionization: H20*+ e + H? + OH' where e is high speed, high-energy electron 
which 
will interact with other atoms or electrons to 
produce more radicals. 
These hydroxyl fiee radicals are the most reactive ones among IR-induced free 
radicals, and since the lifetime of the radicals is about 1 o - ~  seconds, they will not 
diffuse very far fiom the site of formation. The hydroxyl free radicals are concentrated 
alongside the track of the IR beam and will target any substance nearby. They can also 
react with DNA molecules in close proximity targeting mainly DNA bases and sugar 
moieties. 
Most of the free radical mediated DNA damage (-80%) occurs at the double 
bonds of bases resulting in either 6-hydrothymine, 5-hydroxy-5,6-dihydrothymine, 5- 
hydroxymethyluracil, 5-hydroxycytosine, 4,6-diamino-5-formamidopyrimidine, 8- 
hydroxyadenine, 2,6-diamino-4-hydroxy-5-formamidopyrimidine, thymine glycol, or 
8-oxoguanine (Dizdaroglu et al., 1986). These lesions do not produce the lethality 
caused by IR and can be easily repaired by base excision repair (BER). Although 8- 
oxoguanine is a mutagenic lesion where addition of 0 on position 8 of the guanine can 
mispair with A resulting in transversion, it is not considered the main cause of lethality 
observed from exposure to IR. The rest of the damage caused by IR-induced hydroxyl 
radicals (-20%) is on the sugar moieties through the abstraction of hydrogen atoms 
from C1' to C5' of the deoxyribose. Hydrogen abstraction of hydrogen atoms fiom 
these five sites of deoxyribose is a random process and leads to five possible sugar 
radicals, but the main attack which produces strand breaks is on the C4' site of the 
deoxyribose. This is followed by some rearrangements that result in 3'- 
phosphoglycolate and release of base propenal. Thus, the formation of multiple SSBs 
concentrated within close proximity of IR tract results in 25-50 DSBs per 1 gray (Gy) 
of X-ray irradiation in a single diploid mammalian cell, which ultimately contributes to 
the lethality of IR (Erixon et al., 1995). 
Also, similar to IR-induced DSBs, initial attack by radiomimetics such as 
bleomycin cause oxidation of C4' of the deoxyribose of the first C following a G 
(Povirk, 1996). This leads to a strand break or apyrimidine (AP) site. Bleomycin is 
known to be semi-sequence specific and its reactivation can lead to another attack in 
the opposite strand producing a strand break or an abasic site. All breaks are blocked 
by a 3'-PG and are associated with base propenal formation. 
Consequences of DSBs 
The presence of DSBs in a cell can be devastating for its survival if they are left 
unrepaired, because many critical cellular functions such as replication and transcription 
depend on the integrity of DNA. These unrepaired DSBs can result in chromosome 
breaks leading to the loss of genetic material during cell division and can severely 
increase the chance for oncogenic transformation or cell death (Bryant et al., 1985). 
Autosomal recessive diseases such as ataxia-telangiectasia (A-T) and Nijmegen breakage 
syndrome are caused by the inherent inability to protect the genome against occurrences 
of DSBs, and patients with these diseases exhibit hypersensitivity to radiation, increased 
oncogenic transformation, and genomic instability (Varon et al., 1998 and Waldmann et 
al., 1983). Thus, the DNA DSB is thought to be the single most destructive DNA lesion. 
There are other consequences to DSBs when they are inaccurately repaired. Such 
consequences are deletions, f i m e  shift or point mutations in addition to various 
chromosomal abnormalities that may arise from misjoining of DSBs (Obe et al., 1992). 
Chromosomal abnormalities including inversions, reciprocal translocations, acentric, 
dicentric, ring chromosomes and other complex rearrangements have been determined to 
promote global genomic instability and oncogenic transformation in mammalian cells 
(Lengauer et al., 1998 and Wang et al., 1997). Consequently, mammalian cells have 
acquired an ability to accurately repair DSBs through a complex network of recognition 
and repair proteins. 
DSB detection and signaling 
Mammalian cells possess intrinsic cell-cycle signaling pathways that monitor and 
respond to DNA DSBs because of the devastating consequences they bring. Until now, 
most in vitro experiments regarding DSB repair have utilized naked DNA. However, in 
eukaryotic cells, DNA normally exists in a compacted chromatin structure where DNA is 
wrapped around two histone tetramers, H2A, H2B, H3 AND H4, into nucleosome 
complexes (Laskey et al., 1980). It has been shown that when cells are irradiated with IR, 
one of the histone subunits H2AX is immediately phosphorylated on a highly conserved 
serine residue in the C-terminus (Mannironi et al., 1989). Also, the location of 
phosphorylated H2AX was consistently coincident with the location of DSBs (Ohya et 
al., 2002 and Rogaku et al., 1998). This phosphorylation is also known to induce 
'opening' of the compact chromatin structure to presumably allow easier access of DSB 
repair machinery to the breakage site (Downs et al., 2000). Recently, ataxia-telangiectasia 
mutated (ATM) protein has been found to catalyze this critical phosphorylation (Burma et 
al., 2001). ATM is the protein product of the gene mutated in the human genetic disorder 
ataxia-telangiectasia, and patients who suffer from this disease exhibit neuronal 
degeneration, immunodeficiency, sterility, genomic instability, radiation hypersensitivity 
and predisposition to carcinogenesis. Usually, A-T patients develop lymphoma, breast 
carcinoma, or leukemia during their lifetimes. These life-threatening consequences of A- 
T are not coincidental because of the role ATM plays in not only detecting DSBs 
(Anderson et al., 1993) but also in relaying this information to other cell regulatory 
proteins such as p53, hCHKl and hCHK2 in order to arrest cell cycle progression at 
GlIS, G2/M and intra S check points (Falck et al., 2001, Lohman et al., 2001 and Pierce 
et al., 2001). ATM, which belongs to the serinelthreonine kinases of the 
phosphotidylinositol3-kinase (PUK) family, is thought to be one of 'guardians of 
genome' because of its important role in preventing progression of the cell cycle until 
completion of DSB repair (Kim et al., 1999 and Bannister et al., 1993). Another 
serinelthreonine kinase belonging to P13K family that may signal presence of DSB is 
DNA-dependent protein kinase (DNA-PK), which is the gene mutated in severe 
combined immune deficiency (SCID) in mice (Williams et al., 2001). In contrast to ATM, 
which induces cell cycle arrest, DNA-PK may be more heavily involved in signaling 
detection of DSBs to p53 dependent-apoptotic machinery through differential 
phosphorylation of p53 (Wang et al., 1997). 
DSB repair pathways 
DNA DSBs can be repaired through two distinct pathways: Homologous 
recombination (HR) and Non-homologous end joining (NHEJ). The cell seems to choose 
between these two pathways to repair the lesion and the choice primarily depends on 
which phase of the cell cycle it is currently in. If the cell is in between late S and G2 
phase where an intact replicate sequence is available, then HR seems to be the 
predominant mode of repair. If the cell is in GOIG1 to early S phase, NHEJ appears to be 
the dominant mode of repair. Yet DNA repair is not exclusive to one repair pathway. 
Also, the reason NHEJ is considered to be the major pathway of DSB repair lies in the 
fact that most cells in an adult organism are not continuously dividing. It is possible that 
HR may be more important in stem cells that are actively dividing in the lining of the gut, 
mouth, esophagus, epidermal layer of skin, and blood forming tissues, in addition to cells 
with the potential to divide which include hepatocytes, fibroblasts, glandular epithelial 
cells and endothelial cells. 
Homologous Recombination Repair Pathway (HRR) 
HRR is the predominant mode of repair in lower organisms and represents an 
accurate, high fidelity pathway with no sequence loss or addition. This pathway makes 
use of extensive homologies between the damaged strand and an intact homologous 
strand, replacing lost nucleotides at the break site with the help of sequence information 
from the undamaged strand. In HR, DSBs are introduced as an initial event followed by 
resection of the DNA ends in the 5'+3' direction. Single stranded DNA thus derived then 
invades the homologous strand and DNA polymerase, which makes use of the 
information from the intact DNA, fills in the gaps. Following sister-chromatid pairing and 
strand invasion of DNA overhangs, HRR can go in either of two directions. Noncrossing- 
over, resulting from disengagement of Holliday junction (a point of strand crossover) 
followed by DNA pairing and gap filling in the damaged homologue, appears to be 
strongly favored during HRR in mammalian cells. This is quite different from the 
classical microbial pathway, in which the Holliday junctions are resolved by 
endonucleolytic cleavage, with an equal probability of yielding either a crossover or a 
non-crossover event. Holliday junctions are cleaved by resolvases to yield two intact 
DNA strands after ligation. The yeast S. cerevisiae provides an excellent model for 
understanding the biochemistry and genetics of HR. In S. cerevisiae, the -52 epistasis 
group of genes comprising -50-55 and RAD57 (Game, 1993), RAD59 (Bai et al., 
1996), XRS2 (Ivanov et al., 1992) and the MREll/RAD58 genes carries out HR 
(Baurnann and West, 1998). After DSB induction, Rad52 binds to the broken DNA ends 
in order to protect them from exonucleolytic degradation. Resection of the DNA from 
5'33' is possibly through the coordination of the RadSO/Mrell/Xrs2 (Xrs2 is the yeast 
homologue of human NBS) complex. Evidence suggests that the MRN complex 
functions in NHEJ as well. The Rad5O binds to DNA in an ATP-dependent manner 
(Raymond et al., 1993). The Mrel 1 protein has an exonuclease function that is active in 
the 3'+ 5' direction on the ss- and ds-DNA with a preference for recessed 3' ends 
(Shinohara et al., 1992). It also has an endonuclease function critical in meiosis. Next in 
HR, Rad5 1 polymerizes on ss and ds-DNA forming filaments and mediates strand 
invasion in the 3'+ 5' direction (Sung et al., 1994). The human Rad5 1 protein is also 
homologous to the E.coli RecA protein. Strand exchange is stimulated by the addition of 
RPA (Sugiyama et al., 1997). 
BRCAl and BRCA2 are two breast cancer susceptibility genes recently shown to 
be linked with DNA repair by virtue of their BRCT domains, which are a common 
feature of DNA repair proteins (Callebaut et al., 1997). Both proteins interact with Rad5 1 
and co-localize to nuclear foci in response to DNA damage in mitotic cells (Scully et al., 
1997). Recently, it was demonstrated that BRCA2 interacts with RADSl and RPA at the 
site of DSB and helps load RAD5 1 onto DNA or to organize RAD5 1 filaments (Yang et 
al., 2002). Disruption of BRCA2 gene by targeted truncation in mice makes cells from 
them sensitive to UV light and methyl methane sulfonate. The cells arrest in G1 and 
G2/M phases and increased levels of p53 and p21 accompany this arrest (Pate1 et al., 
1998). Mouse fibroblasts with BRCA1-1- and BRCA2-1- status develop spontaneous 
chromosomal aberrations, providing further evidence for the role of these proteins in 
HRR (Pate1 et al., 1998). Altogether, BRCAl and BRCA2 are believed to be important at 
early points of HRR and perhaps coordinate repair with other cellular processes. 
Attempts to assess the biological consequences of defects in specific HRR factors 
have been hampered by the embryonic lethality of many mouse knockouts targeting genes 
involved in HRR. RAD54 knockout mice are viable, and embryonic fibroblasts of HRR- 
defective RAD54 knockout mice are radiosensitive (Essers et al., 1997,2000). RAD54 
deficiency does not confer radiosensitivity in otherwise normal adult mice, but futher 
enhances the radiosensitivity of NHEJ-deficient Scid mice (with a mutation in DNA- 
PKcs). These results suggest that HRR may be a more important repair component in 
embryonic cells than in normal adult somatic cells. Studies of both knockout mice and 
repair-deficient cultured cells suggest that disruption of any factor involved in HRR 
results in chromosomal instability and (for those defects that are not lethal) cancer 
predisposition (Thompson and Schild, 2001; van Gent et al., 2001). 
Non-Homologous End-Joining Pathway 
This is the second major pathway of DSB repair and is the predominant 
mechanism of repair in mammalian somatic cells. The term "non-homologous" is used to 
indicate the fact that this pathway does not require extensive homologies between two 
DNA strands to be recombined (Roth et al., 1985), although micro homologies of as little 
as 1-5 base pairs are often used (Labhart, 1999; Critchlow and Jackson, 1998). A 
deficiency in this pathway leads to a myriad of consequences like radio-sensitization, 
increased susceptibility to development of cancer and a variety of immunodeficiency 
syndromes, most if not all of which are due to the defect in the repair of DSBs. Over 
more than a decade, genetic and biochemical approaches have now identified the major 
proteins that play a crucial role in this repair process. NHEJ involves a DNA-binding 
heterodimer of Ku70 and Ku80 proteins, which associates with the catalytic subunit of 
DNA-dependent protein kinase (DNA-PKcs) to form DNA-PK holoenzyme. Additional 
factors include DNA ligase N, its cofactor XRCC4 and probably DNA polymerase h 
and/or human polynucleotide kinaselphosphatase or hPNKP (Critchlow and Jackson, 
1998; Jackson and Jeggo, 1995; Chu, 1997). Ku was first identified as an autoantigen for 
a number of autoimmune diseases in 1981, but Rathrnell et a1 linked it to NHEJ when 
they observed that Ku complementation conferred X-ray resistance to X-ray sensitive 
hamster cell line, xrs5. Subsequently, several X-ray cross complementation (XRCC) 
genes were identified by virtue of their ability to correct radiation hypersensitivity in 
rodent cell lines. They are XRCC4, XRCCS, XRCC6 and XRCC7 encoding the proteins 
XRCC4, Ku86, Ku70 and DNA-PKcs respectively. With these discoveries, a host of 
other genes that are now known to be integral players in recognition, signaling, and repair 
of DSBs have begun to emerge. And the list is increasing at an extraordinary pace 
implicating additional factors such as hMrel 1, hRad50, Nbsl, APE1, Artemis and 
Werner, as well as many additional proteins involved in downstream signaling. 
Structural and biochemical properties of end-joining proteins 
Ku Heterodimer 
As subunits of DNA-dependent protein kinase, Ku70 and Ku86 are proteins with 
molecular weights of 70 and 86 kDa respectively. This Ku heterodimer forms a close- 
fitting asymmetrical ring that threads onto a free end of DNA as a "nut on a bolt" (Walker 
et al., 2001). Also, using nitrocellulose filter-binding assay, its affinity toward dsDNA has 
been determined to be much higher than toward ssDNA (Walker et al., 2001). The 
dissociation constant of Ku towards ds DNA is in the range of 1-2 nM while that for 
single-stranded DNA is about 300nM (Tuteja and Tuteja, et al., 1994). Later studies 
showed that Ku can also bind to gapped and nicked DNA as well as to DNA hairpins 
such as those generated during V(D)J recombination (Blier et al., 1993; Falzon et al., 
1993). Although Ku tends to cling to the DNA end, it can translocate into the interior, 
allowing multiple Ku heterodimers to load onto longer DNA molecules (Mimori et al., 
1986; Yaneva et al., 1997). The end-bound Ku occupies approximately 16- 1 Sbp, as 
indicated by X-ray crystallography, DNase footprinting (Lee et al., 2004) and ultraviolet 
crosslinking (Walker et al., 2001). The primary hc t ion  of Ku70186 in NHEJ, which is 
alignment of two DSB ends for subsequent repair processes to ensue, has been suggested 
fiom their ability to self-associate. In order to bind to DNA, both subunits of Ku should 
be present and interact with each other (Griffith et al., 1992). Also, in a DNA sequence- 
independent manner, the self-association of Ku molecules that form either DNA loops 
(intramolecular interaction) or DNA intermolecular bridges has been observed through 
atomic force microscopy (Cary et al., 1997). In addition to acting as a DSB alignment 
factor, Ku recruits DNA-PKcs molecules to DSB ends and forms a stable complex while 
stimulating its kinase activities (Dvir et al., 1992; Gottlieb and Jackson, 1993). It is also 
known to stimulate the catalytic activities of DNA ligase IV (Cary et al., 1997). A search 
for homology between the cDNAs of the 2 subunits of Ku led to the identification of 
leucine zipper motifs (Wu and Lieber, 1996) which suggested a role for Ku in regulation 
of transcription and ATP binding domains in both Ku70 and Ku80 which were thought to 
be essential for ATPase function of Ku (Cao et al., 1994). In addition to the ATPase, Ku 
was reported to unwind duplex DNA and was thus classified as human DNA helicase IT 
(Tuteja et al., 1994). It unwinds DNA duplexes in a 3'+ 5' direction on the bound strand. 
The ATPase function is attributed to both the subunits whereas the helicase is entirely a 
function of Ku70 (Ochern et al., 1997). 
DNA-PKcs 
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is the largest 
component of the DNA-PK holoenzyme. It is a -460 kDa serinelthreonine kinase that 
belongs to the subgroup of PIK-related kinases within the phosphatidylinositol (PI)-3 
kinase superfamily (Hartley et al., 1995). All the members of this subgroup have a 3' 
conserved kinase domain similar to the lipid kinases, but in addition also have another 
conserved domain 3' to the kinase domain. DNA-PK was purified from Hela nuclear 
extracts as a protein that was able to phosphorylate DNA binding proteins like p53, SV40 
large T antigen and Ku (Carter et al., 1990; Jackson et al., 1990; Lees-Miller et al., 1990). 
Monoclonal antibodies against the 460 kDa kinase specifically inhibited the kinase 
activity from the cell extracts. Immunodepletion of the protein also abolished the kinase 
activity (Carter et al., 1990). Two smaller polypeptides were also isolated with the 460 
kDa DNA-PK and sequence analysis revealed that they were in fact the 2 subunits of Ku 
that co-purified with DNA-PK (Lees-Miller et al., 1990). Subsequent studies showed that 
DNA-PK binds to and is activated by binding to dsDNA ends (Gottlieb and Jackson, 
1993). They also showed that when Ku was mixed with the 460 kDa protein fractions, it 
stimulated the kinase activity of those fractions. Pre-incubating cell extracts with anti-Ku 
antibodies abolished the kinase activity. All these observations suggested that Ku was a 
component of DNA-PK and was required for dsDNA dependent stimulation of DNA-PK. 
However, this is not true in its entirety because it was later shown that DNA-PK is not 
activated by many substrates that are efficiently bound by Ku like hairpins, nicks (Smider 
et al., 1994) and cis-platin cross-linked DNA (Turchi et al., 2000). Furthermore, DNA- 
PKcs can be activated in the absence of Ku as long as the concentration of DNA ends is 
sufficiently high and ionic strength sufficiently low to support DNA-PKcs binding to the 
DNA ends (Hammarsten and Chu, 1998). This suggested that DNA-PKcs was activated 
by its direct interaction with dsDNA and that Ku was needed just to stabilize this binding. 
An electron crystallography study revealed that the DNA-PKcs structure contains and 
open channel, and an enclosed cavity with three openings large enough to allow the 
binding of a single-stranded DNA (Leuther et al., 1999). The results from ultraviolet 
crosslinking studies suggest that, when a DNA-PKcs molecule binds a DNA terminus, it 
displaces Ku approximately1 0 bp interior away fiom the terminus (Yoo and Dynan, 
1999). Formation of the DNA-PK holoenzyrne complex (Ku and DNA-PKcs) on a DNA 
end results in the activation of its kinase activity (Smith and Jackson, 1999). Studies with 
various oligomeric substrates suggest that activation involves insertion of a few bases of 
the single strands into defined channels (Hammarsten and Chu, 1998). Activation is 
relatively insensitive to structural modifications in these single strands, suggesting that 
even severely damaged termini could still activate DNA-PK (Weinfeld et al., 1997; 
Martensson and Hammarsten, 2002). 
Activated DNA-PK phosphorylates a variety of DNA-binding proteins (Anderson 
and Lees-Miller, 1992), including several with known or putative roles in end-joining 
such as Ku (Lees-Miller et al., 1990), XRCC4 (Leber et al., 1998), Werner (Yannone et 
al., 2001) and the Artemis nuclease (Ma et al., 2002). Activated DNA-PK also 
phosphorylates itself, resulting in its dissociation from DNA (Chan and Lees-Miller, 
1996). Pharmacological inhibitors of PI-3 kinase family can also regulate DNA-PK 
activity. Wortmanin, a sterol-like fungal metabolite, is one such potent and selective 
inhibitor of mammalian PI-3 kinases (Ui et al.,1995; Powis et al., 1994). A detailed 
kinetic analysis of wortmanin mediated DNA-PK inhibition showed that wortmanin 
inhibits DNA-PK in a non-competitive manner with a Ki of 120nM (Izzard et al., 1999). 
The compound forms a covalent bond with the kinase domain of DNA-PKcs in vivo and 
in vitro and this binding is not dependent on presence of Ku (Izzard et al., 1999). 
LY294002 is another potent inhibitor of DNA-PK and other PI-3 kinases (Rosenzweig et 
al., 1997) LY294002 also sensitizes human tumor cells to IR at the same concentration 
required to inhibit DNA-PK activity. 
XRCCW DNA Ligase IV 
The XRCC4 gene was originally isolated by complementation of radiosensitivity, 
V(D)J recombination deficiency and DSB repair deficiency of the radiosensitive CHO 
derivative XR-1 (Li et al., 1995). As revealed by X-ray crystallography, XRCC4 consists 
of a globular head plus a long a-helical tail. In the crystal, four XRCC4 monomers form a 
dumbbell shaped homotetramer with two globular heads at each end and the ends linked 
by the four interacting tails (Junop et al., 2000). In cells, DNA ligase IV is present in a 
tight complex with XRCC4 and the complex can withstand buffer conditions of 2 M 
NaCl or 7 M urea (Lee et al., 2000). Ligase IV is not detectable in cells lacking XRCC4, 
but XRCC4 is stable by itself (Bryans et al., 1999). Ligase IV binds to XRCC4 at a site 
near the middle of the a-helical tail. A unique characteristic of DNA ligase IV is a large 
C-terminal region containing tandem repeats of BRCT domain, a motif commonly found 
in proteins involved in DNA repair and DNA damage signaling, which is also responsible 
for interacting with XRCC4 (Sibanda et al., 2001). In addition, it is the only DNA ligase 
that is able to maintain its catalytic activity in low magnesium concentration such as in 1 
mM. The role of XRCC4lDNA ligase IV in NHEJ has been extensively investigated 
through its interaction with other proteins of the NHEJ machinery. Electrophoretic 
mobility shift assay and immune-precipitation show that Ku physically interacts with the 
complex and recruits it to DNA (McElhinny et al., 2000). The interaction of 
XRCC4Aigase IV with DNA is stabilized only in the presence of Ku, but DNA is not 
required for the interaction of Ku with the complex. Chen et al., in 2002, found that under 
their experimental conditions, Ku actually inhibits intramolecular ligation by 
XRCC4Aigase IV suggesting that this complex is rather complex. XRCC4 also interacts 
with DNA-PKcs and is an effective substrate for phosphorylation by DNA-PKcs, but the 
relevance of this phosphorylation to NHEJ is still unclear. Phosphorylation occurs on 
serine and threonine residues in the carboxy-terminal of the protein (Leber et al., 1998). 
Oxidative Stress and DSBs 
Oxidative stress plays a major role in aging and in many human diseases, 
including cancer and various neurological disorders (Lu et al., 2004). The primary known 
targets of oxidative damage are cell membranes and DNA. Ionizing radiation, 
radiomimetic drugs, and to some extent, all fiee radical based genotoxins induce DNA 
DSBs either by base release or oxidative fragmentation of DNA sugars (Inamdar et al., 
2002). In particular, oxidation of the C-4' position results in breaks with 5'-P and 3'-PG 
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termini. Repair of such breaks requires the conversion of these modified 3' termini to 3' --\ 
hydroxyls, so that DNA polyrnerases can replace the missing nucleotide and DNA ligase 
can seal the nick. At single-strand breaks in double-stranded DNA, conversion of both 3'- 
P and 3'PG termini to 3'-hydroxyl termini were found to be catalyzed by the human basic 
endonuclease, Apel '(Suh et al., 1997). However, 3'-PG termini in single-stranded 
segments of DNA, such as 3' overhangs of DNA DSBs, are completely refractory to Apel 
(Chaudhry et al., 1999). The human polynucleotide kinaselphosphatase PNKP, which 
removes 3'-P from single-stranded 3' termini, also has no detectable effect on 3'-PGs 
(Jilani et al., 1999; Karimi-Busheri et al., 1999) and this is similar to reports for rat PNKP 
(Habraken and Verly, 1988). The susceptibility of 3'-PGs to E. coli exonuclease I 
(Sandigursky and Franklin, 1993) raised the possibility that PGs on 3' overhangs might be 
removed by a mammalian 3 '3  5' exonuclease. However, DNase III, which is the 
dominant 3 ' 3  5' exonuclease in mammalian cell extracts, has no detectable effect on any 
3'-PG substrates (Inamdar et al., 2002). The Wml and Mrel 1 3'+ 5' exonucleases are 
also unlikely candidates to these enzymes (Kamath-Leob et al., 1998; Huang et al., 2002). 
Nevertheless, it was shown that Xenopus, human and hamster whole cell extracts possess 
potent activity for processing of PGs on single-stranded 3'overhangs of DSBs, as well as 
from simple single-stranded oligomers (Chen et al., 2001). 
Tvrosvl DNA phosphodiesterase 
Topoisomerases are essential ubiquitous cellular enzymes required to control the 
superhelical tension and DNA entanglement associated with DNA replication, 
recombination, transcription and chromosome segregation (Connelly and Leach, 2004). In 
eukaryotes, topoisomerase I transiently breaks one strand of DNA, forming a covalent 
linkage between the side chain of its active site tyrosine and a 3' P of DNA, subsequently 
reversing it to re-ligate the DNA. Although this activity is essential for survival, 
topoisomerase I can be toxic. When the enzyme cleaves DNA at or near a variety of DNA 
lesions, the re-ligation step is hindered and topoisomearse I remains on the DNA as a 
covalent 'cleavable complex'. The initial DNA lesion is thereby transformed unto a 
single-strand break that is encumbered with a protein adduct. Cleavable complex 
formation is also induced by chemotherapeutic agents, such as captothecin (CPT), that 
specifically inhibit topoisomerase I re-ligation. An encounter with a replication fork 
converts the cleavable complex into a potentially lethal DSB. Tyrosyl DNA 
phosphodiesterase 1 (Tdpl) was first isolated from Sacchromyces cerevisiae as an 
enzymatic activity that precisely cleaves this tyrosyl-phosphodiester bond linking tyrosine 
of topoisomerase I to a 3' DNA end (Yang et al., 1996). Subsequently the S. cerevisiae 
gene for Tdpl was cloned and characterized, and orthologs were identified in other 
eukaryotic but not prokaryotic species. 
Previous experiments in yeast presented two lines of evidence showing that Tdpl 
is a repair protein that only acts after the occurrence of a DSB. First, biochemical studies 
with highly purified Tdpl showed that the enzyme is most active on substrates that mimic 
DNA that has a topoisonierase I-linked DSB and is less active on a substrate that 
resembles an unprocessed cleavable complex. Second, an analysis of the phenotype of 
single and double mutants shows that the in vivo repair of topoisomerase I lesions by 
Tdpl depend on the function of the RAD52 gene, which is known to be vital for DSB 
repair. Taken together, these results for the first time placed tdpl in a RAD.52-dependent 
DSB repair pathway. Surprisingly, a S.cerevisiae strain containing a null mutation in the 
tdpl gene is no more sensitive to CPT killing than the wild-type strain. However, when 
the tdpl null mutation of S. cerevisiae was added to a rad9 mutation there was a 10-fold 
increase in the lethal effects of CPT, suggesting that there are other, Tdpl -independent, 
pathways of repair. The RAD9 gene is vital for the function of a DNA damage 
checkpoint. Since it is also critical for DNA damage-induced expression and the post- 
translational modification of several genes, it is possible that an important component of 
the Tdpl -independent pathway might be limiting in a rad9 strain. Subsequent genetic 
studies in yeast have revealed at least two other separate pathways that can contribute to 
the repair of topoisomerase I-DNA covalent complexes. These include the structure- 
specific endonucleases RadllRad10 and Mus8 1 M s 4 .  Deletion of the MUS81 confers 
sensitivity to CPT apparently through a pathway parallel to Tdpl and Radl as the triple 
mutant tdpl radl mus81 is more sensitive than the double-mutant tdpl radl. 
Experiments using a genome wide screen to detect all non-essential genes that are 
important for protection fiom growth inhibition or killing produced by continuous 
exposure to CPT helped identify two further pathways involved in repairing the Topl- 
DNA complex, one involving S1x4 which acts in a parallel pathway to Tdpl and 
RadlIRadlO, and Sae2 which appears to act by stimulating the endonulcease activity of 
Mrel 1 . 
Evidence for a 3'-P intermediate in 3'-PG removal in human cell extracts 
suggested possible involvement of hTdpl, and indeed, both hTdpl and yTdpl were found 
to catalyze similar glycolate removal from a single-stranded oligomer as well as fiom a 
single strand overhang of a DSB (Inamdar et al., 2002). Yeast and human Tdpl differ 
from other activities for processing blocked 3' ends in that they leave behind a 3'-P rather 
than a 3'-hydroxyl. The 3'-P can then be removed by PNKP (Jilani et al., 1999; Karimi- 
Busheri et al., 1999). 
The exact step of NHEJ at which Tdpl acts is yet unknown. Kinetic studies show 
that at least in extracts, much of the PG removal from 3' overhangs occurs within the first 
few minutes, suggesting that it does not require the formation of the full repair complex 
(Inarndar et al., 2002). Indeed, the kinetic data suggest that as the ends become 
sequestered by DNA-PIS, PG-removal is dramatically suppressed, raising the possibility 
that there maybe additional 3'-PG processing enzymes that act in context of the repair 
complex. 
Tdpl is a member of the phospholipase D superfamily 
The members of the PLD superfamily comprise a highly diverse group of proteins 
that include plant, mammalian and bacterial PLDs, bacterial phosphatidyl-serine and 
cardiolipin synthases, a bacterial toxin, several pox-virus envelope proteins, and some 
bacterial nucleases. 
Recent database searches revealed a hll-length human cDNA encoding a 608-aa 
Tdpl ortholog (68.5 kDa) located on chromosome 14. Predicted Tdpl orthologs are 
present in a number of other eukaryotic organisms. The homology between the Tdpl 
orthologs from different species extends from approximately amino acid 150 of the 
human protein to the C terminus. The N-terminal regions of the Tdpl orthologs are 
poorly conserved and vary substantially in length. Among the regions that are best 
conserved are amino acids 262-289 and 492-522 of the human protein. A sequence 
alignment of these conserved regions with motifs 3 and 4 of representative members of 
each class within the PLD superfamily reveals a high degree of similarity. Importantly, 
motifs 3 and 4 encompass the highly conserved HKD sequence identified as a hallmark of 
the PLD superfamily. In both Tdpl and the members of the PLD superfamily, the 
conserved histidines, lysines, and aspartic acidss that form the HKD motif, surround the 
active site pocket. However, a conserved aspartate, positioned a long way from the active 
site and important for protein folding and stability, is present only in the PLD superfamily 
members and not Tdpl. Furthermore, the remainder of the human Tdpl protein sequence 
cannot be reasonably aligned with any of the other PLD family members. Based on these 
findings, it was indicated that the Tdpl orthologs represent a distinct class within the 
PLD superfamily. 
As a member of the PLD superfamily, human Tdpl is predicted to require a 
combination of two histidines (H263 and H493) and two lysines (IS265 and K495) for 
catalytic activity. Biochemical experiments and the crystal structure of human Tdpl 
confirm this prediction and demonstrate that the reaction proceeds through an 
intermediate in which the active site H263 is covalently bound through a phosphoamide 
bond to the 3' end of the DNA moiety of the substrate. In the second step of the reaction, 
hydrolysis of the covalent intermediate yields the DNA product and frees the enzyme. 
Substrate specificity of Tdpl 
Role of Tdpl in SSB repair 
DNA SSB repair is critical for the survival and genetic stability of mammalian 
cells. SSBs can arise either directly (e.g., from attack of deoxyribose by free radicals such 
as ROS) or indirectly (via enzymatic cleavage of the phosphodiester backbone, e.g., as 
normal intermediates of DNA BER). SSB repair can be divided into four basic steps, 
beginning with DNA damage binding. The second step in SSB repair is DNA end 
processing followed by DNA gap filling. In the final step, the integrity of the 
phosphodiester backbone is restored by DNA ligation. 
In yeast, Tdpl has been implicated in the repair of topoisomerase I-DNA adducts 
via the DSB repair pathway, although it is also clear that additional Tdpl -independent 
repair pathways can also correct topoisomerase I-mediated lesions. However, the role of 
Tdpl in mammalian cells is not well understood. Its role in SSB repair is controversial. 
Early papers have proposed that Tdpl participates in SSB repair. In humans, a mutation 
that inactivates Tdpl in vitro is associated with inherited Spinocerebellar ataxia with 
axonal neuropathy or SCAN1. This result was initially surprising since DSBs form as a 
result of DNA replication in yeast and the inability to repair topoisomerase I-DNA 
adducts should not preferentially affect non-dividing neuronal cells. This observation 
therefore led to the proposition that Tdpl acts via a SS repair pathway since SSBs can 
result from the collision of transcription complexes with abortive topoisomerase I-DNA 
adducts. A variety of recent observations have also been used to argue that SSB repair 
pathways are the preferred routes for repairing topoisomerase I-cleavage complexes in 
mammalian cells. First, cells containing inactive SSB repair proteins and XRCCl are 
hypersensitive to CPT. In addition, yeast two-hybrid experiments revealed that Tdpl 
associates with the SSB repair machinery by direct interaction with DNA ligase ma, a 
partner of XRCC1, a scaffold for repair proteins involved in SSB repair in higher 
eukaryotes. This might account for the observation that Tdpl co-immunoprecipitates with 
XRCC1. Based on this result, it has been proposed that XRCCl DNA repair complexes 
contain enzymes required to excise the topoisomerase I-DNA adduct (Tdpl), process the 
DNA strand (PNKP), replace the missing DNA segment (P-polymerase), and seal the 
DNA in the absence of a DSB (ligase m). Therefore, one would expect the nicked or 
tailed substrate (mimicking a gapped DNA duplex) to be good substrates for Tdpl . 
Recently, Raymond et al. (2005) presented results showing that Tdpl does not 
have a kinetic or binding preference for single strand DNA over blunt end duplex DNA. 
The paper suggested that both single strand and double stranded blunt DNA substrates 
have significantly higher specificity constants (kat/KM) over nicked or tailed substrates. It 
was also shown that Tdpl binds single stranded and double blunt stranded substrates with 
significantly higher affinity (lower KD) than with nicked or tailed substrates. Because 
single stranded DNA is not expected to be a common substrate in vivo, the authors 
proposed that double stranded blunt DNA is the natural substrate in vivo. If this is the 
case, these studies clearly suggest that Tdpl acts after the topoisomerase I-mediated 
damage is converted to a DSB. 
Proposed mechanism of action of Tdpl 
SCAN1 
The association of human genetic disorders with defects in the DNA damage 
response is well established. Most of the major DNA repair pathways are represented by 
diseases in which that pathway is absent or impaired. Hereditary ataxia comprises a 
clinically and genetically heterogeneous group of diseases that include disorders in DNA 
repair, such as AT, XP and Cockayne syndrome. In contrast to the isolated forms of 
hereditary ataxia, disorders of DNA repair typically cause additional syniptoms, such as 
mental retardation, photosensitivity, immunodeficiency and neoplasia. A homozygous 
recessive mutation in the human TDPl gene (A1478G) that results in the substitution of 
H493 with an arginine residue was found to be responsible for the human hereditary 
disorder SCANl. The ataxia first becomes noticeable in the teenage years and apparently 
results from an effect on non-dividing terminally differentiated neuronal cells. SCANl is 
characterized by peripheral axonal motor and sensory neuropathy, distal muscular 
atrophy, and steppage gait. The association of a DNA repair protein with SCANl is 
striking, in that this is a neuro-degenerative disease that lacks any obvious 
extraneurological features such as genetic instability or cancer. 
The A1478G mutation was originally proposed to be a loss of function mutation 
but a recent paper (Interthal et al., 2005) has suggested that the H493R mutation reduces 
the activity of the enzyme only -25-fold based on the rate of product formation by the 
purified enzyme. This small amount of residual activity maybe sufficient to provide most 
of the repair capacity required throughout the life of an individual and thus explains the 
late onset of the disease in SCANl individuals. Alternatively, similar to yeast, there 
maybe a functional overlap of other repair systems so that, in the absence of sufficient 
Tdpl activity, other pathways capable of repairing topoisomerase-I DNA covalent 
complexes fulfill the needs of the organism. 
It is not known yet whether a SSB repair process or a DSB repair process 
is defective in SCAN1 .Quantitative y-H2AX irnmunostaining and neutral comet assays to 
examine whether the breaks that accumulate in SCANl cells are SSBs or DSBs, were 
carried out. Neither assay revealed a measurable difference between the level of DSBs in 
non-replicating normal and SCANl cells. Consequently, it was assumed that since both 
assays can detect as little as 1-2 Gy equivalents of DSBs, more than 98% of the breaks 
that accumulate in non-replicating SCANl cells are SSBs. But at the same time, there 
have been suggestions of XRCC1 involvement in DSB repair pathway. A protein partner 
of XRCC1, PAW-1, binds both SSBs and DSBs, and in NHEJ defective background, the 
additional disruption of PAW-I results in embryonic lethality. This has raised the 
possibility that PARP-1 iiilfills a back up role during DSB repair, by binding and 
recruiting XRCC1 and other SSB repair proteins to DSBs that are not repaired by 
classical NHEJ. 
It remains unclear why neurons are specifically affected by the Tdp 1 defect in 
SCANl individuals. One possibility is that the elevated oxidative stress in post-mitotic 
neurons creates a particularly high level of SSBs. In addition, the limited regenerative 
capacity of the nervous system might render this tissue particularly susceptible to cell 
loss. Another possibility might be that unrepaired SSBs can be processed by HR, in 
proliferating cells, even in the absence of Tdpl, once they have been converted to DSBs 
during DNA replication, as in budding yeast. Terminally differentiated neurons have an 
enhanced need for Tdpl -mediated repair or are hypersensitive to the effects of persistent 
topoisomerase I-DNA covalent complexes, perhaps because alternative pathways may be 
attenuated in differentiated neurons. Interestingly, CPT was shown to induce apoptotic 
cell death in post-mitotic cortical neurons, indicating an important replication- 
independent role for topoisomearse I in this cell type. 
Other roles of Tdpl 
Tdpl may also have multiple roles in the cell. For example in Drosophila, Tdpl 
has been shown to be essential for the formation of epithelial polarity and for neuronal 
development during embryogenesis, and it has been proposed that Tdpl is involved in the 
localization of membrane proteins (Dunlop et al., 2004). Although no substrate or 
mechanism has been proposed to support this function, Tdpl is a member of the PLD 
superfamily of enzymes (Interthal et al., 2001) and other members of this superfamily 
participate in membrane vesicle trafficking by hydrolyzing phosphatidylcholine to 
generate phosphatidic acid (Hughes et al., 2004; Humeau et al., 2001). These results 
emphasize the importance of understanding the in vitro binding properties and catalytic 
mechanism of Tdpl to better understand its biological role(s). 
Materials and Methods 
Polyacrylamide gel electrophoresis 
For denaturing gels, 8 M urea solution containing 20: 1 acrylamide: bisacrylarnide 
solution was prepared. Urea was allowed to dissolve at low heat and the mixture was then 
allowed to cool to room temperature. Polymerization was initiated by addition of 0.075% 
(w/v) arnmonium persulfate and further accelerated with 0.03%(v/v) TEMED (N', N', 
N', N'-tetra methylethylene). The gel was allowed to set for - lhour after which samples 
were loaded onto the gel and electrophoresed at a constant power of 40 to 50 watts 
depending on the size of the gel for 3 to 6 hours respectively. For end-processing assays, 
the gel was frozen and exposed on PhosphorImager screens for 1-2 days at -20' C. 
Phosphor images were analyzed and bands were quantified using ImageQuant software 
(Molecular Dynamics). For labeling of oligonucleotides with 3 2 ~ ,  the gel was exposed to 
X-ray film for approximately 30 seconds to 1 minute. The film was transilluminated 
against white light and the bands on the film were lined up with the gel. The part of the 
gel corresponding to the bands was cut and placed in 6 mL of 0.3 M sodium acetate/ 1 
mM EDTA and allowed to elute at room temperature over night. On the second day, the 
elute was removed, divided into 1 mL eppendorf tubes and vacuum dried until all the 
liquid evaporated and left behind a white residue. The residue was dissolved in 800 pL of 
deionized water and mixed with 800 pL of 0.2 M triethylamine. The oligonucleotides 
were then subjected to high-pressure liquid chromatography (HPLC). 
High-pressure liquid chromatography (HPLC) 
DNA oligonucleotides were purified by the use of reverse phase high pressure 
liquid chromatography (HPLC). Reverse phase means that the gradient starts with a more 
aqueous mobile phase and progresses to a more hydrophobic mobile phase. 
Chromatography was carried out using a Rainin 5 p.M Microsorb C18 column and 2 
buffers, buffer A (5 % acetonitrile, 0.1 M triethylammonium acetate pH 7) and buffer B 
(50% acetonitrile, 0.1 M triethylammonium acetate pH 7). Glacial acetic acid was used to 
adjust the pH of the buffers while the use of NaOH was prohibited to avoid salt build up 
in the column. DNA interacts with column via the triethylamine present in the buffer. The 
negative charges of the DNA phosphate backbone are attracted to positively charged 
mine groups. Furthermore, the ethylene groups of triethylamine mediate interactions 
with the carbon chains. This DNA-triethylamine- CI8 column interaction is hindered as 
the acetonitrile concentration is increased through a computer-controlled gradient directly 
competing for triethylamine until the DNA is eluted. First, the column was flushed with 
buffer B for 10 min to expel any residues fiom previous use. Then, the column was 
flushed with buffer A for 10 min. Next, the linear gradient was activated which mainly 
hct ions to increase the mobile phase acetonitrile percentage fiom 5% to 30% over 60 
min by controlling the buffer flow fiom buffer A and B. the DNA oligo sample dissolved 
in 0.1 M triethylamine to a volume of 800 pL was injected into the sample loading port. 
With a flow-rate of 1 mumin, the content of the effluent was monitered by a 
photomultiplier-tube detector and was recorded on the polygraph. After 20 to 30 min, the 
oligonucleotides eluted and the elute was vacuum dried for approximately 4 to 6 hours. 
After the oligo was completely dried, it was resuspended in TE buffer (1 0 rnM Tris-HC1 
pH 8,O.l mM EDTA). 
Whole-cell extract preparation from human lymphoblastoid cells (GM0058B) 
The procedure described by West and Bawnann, 1998, PNAS was used. Cell lines 
were purchased from NIGMS Human Genetic Mutant Cell Repsotiory (Camden, NJ). 
GM0058B was a normal transformed cell line fiom a young 26-year old Caucasian. Cells 
were cultured in suspension in Rosewell Park institute medium (RPMI 1640) with 10% 
fetal calf serum (FCS) and allowed to grow to a density of 8 x 10' cells/ml before 
harvesting. They were then washed once in RPMI 1640 containing 10% FCS and once in 
ice-cold phosphate buffered saline (PBS) before transporting to the laboratory for extract 
preparation. Cells were received re-suspended in 200 ml of RPMI 1640. A sterile 
centrifuge bottle was weighed and the cells were transferred to the bottle and spun down 
at 1200 rpm for 10 minutes in the SS34 rotor. The cell pellet was re-suspended in 200 ml 
of ice-cold PBS and washed two times. PBS was then discarded and the cells were 
washed with hypotonic lysis buffer containing 10 rnM Tris-HC1, ph 8.01 1 mM EDTAI 5 
rnM Dm. A 2 ml pellet was obtained at the end of the final wash, which was the re- 
suspended in 2 volumes (4 ml) of hypotonic lysis buffer again. Cells were allowed to 
swell for about 20 minutes on ice after which they were transferred to a 7 ml tissue 
homogenizer and cells were lysed with 20 stokes of pestle "A". The following protease 
inhibitors were added in appropriate concentrations-phenylmethylsulfonyl fluoride, 0.17 
mgtml; aprotinin, 0.01 trypsin inhibitors units1 ml; leupeptin, 1 Wml; pepstatin, 1 pgml 
and chymostatin 1 pglml. The homogenizer with the lysed cells was put on ice for 20 
minutes. After 20 minutes, the lysate was transferred to a 50 ml centrifuge tube and 0.5 
volumes (3 ml) of high salt buffer (50 mM Tris-HC1, pH 7.51 1 M KC11 2 mM EDTAf 2 
mM DTT) was added. The total 9 ml volume was then subjected to high-speed 
centrifugation. A Beckman SW 50.1 rotor with six-buckets was used. The initial weight 
of the buckets was noted down. The extract was divided into equal volumes and 
transferred to Beckrnan centrifuge tubes. The buckets were weighed again after placing 
the tubes in them. The weight of each bucket was balanced against each other to within 
0.001 g. the buckets were then transferred to a Beckrnan ultracentrifuge, which was pre- 
cooled to 4OC before putting the buckets in. the extract was then centrifuged for 3 hours 
at 42000 rpm. After 3 hours, the SW 50.1 rotor was removed and the contents showed 
three distinct layers; a top layer of cellular fat, the second layer of clear supernatant and 
the third layer of cell debris. The clear supernatant was carefully aspirated out using a 20 
G hypodermic needle and a 3 ml syringe. The extract was then transferred to a pre-treated 
dialysis tubing of M.W. exclusion range between 6000-8000 Dalton and dialyzed for 3 
hours in a buffer containing 20 mM Tris-HC1, pH 8.01 0.1 M potassium acetate1 20% 
(vlv) glycerol1 0.5 rriM EDTAI 1 rnM DTT. The dialyzed extract was then divided into 50 
and 100 pl aliquots and transferred to cryo-freeze vials, flash fiozen and stored at -70°C 
until further use. Protein concentration of the extract was determined using the Lowry 
protein assay. For each batch of extract, an - 10-12 mglml protein concentration was 
obtained. 
Purification of DNA from non-competent cells using QIAamp DNA Minikit 
6 ml LB medium (10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaC1, 1N NaOH, 
1M MgS04 and 1% glucose) containing 25 mglml ampicillin with plasmid containing 
E.coli bacterial colony was incubated overnight at 37OC. Bacteria were then pelleted by 
centrifugation for 10 minutes at 8000 rpm. The bacterial pellet was resuspended in 180 pl 
ATL buffer to which 20 pl Proteinase K was mixed by vortexing. The mixture was 
incubated at 56OC in a shaking water bath for 2 hours or until the tissue is completely 
lysed. The microcentrifuge tube was briefly centrifuged to remove drops from the inside 
of the lid. 4 pl of 100 mg/ml Rnase A was added and the mixture was mixed by pulse- 
vortexing for 15 seconds and then incubated for 2 minutes at room temperature. The tube 
was centrifuged briefly to remove drops and 200 pl buffer AL was added to the sample. 
The tube was again pulse-vortexed for 15 seconds and incubated for 10 minutes at 70°C. 
200 pl of 96-1 00 % ethanol was added and mixed by pulse-vortexing for 15 seconds. 
Once again the tube was briefly centrifuged to remove drops. Next, the mixture 
(including precipitate) was carefully applied to the QIAarnp spin column in a collection 
tube (2 ml) without wetting the rim. The cap was closed and the tube was centrifuged at 
8000 rprn for 1 minute. The spin column was placed in a clean collection tube and the 
tube containing the filtrate was discarded. The spin column was carefully opened and 500 
pl of buffer AW 1 was added without wetting the rim. . The cap was closed and the tube 
was centrifuged at 8000 rpm for 1 minute. The spin column was placed in a clean 
collection tube and the tube containing the filtrate was discarded. 500 pl of buffer AW2 
was then added to the spin column without wetting the rim and centrifuged at 14000 rprn 
for 3 minutes. The spin column was placed in a new 2 ml collection tube and centrifuged 
at 14000 rprn for 1 minute. Once again the spin column was placed in a clean collection 
tube and 200 pl buffer AE was added to the tube which was then incubated at room 
temperature for 5 minutes and centrifuged at 8000 rpm for 1 minute. The latter elution 
step was repeated 3 times and finally the purified DNA was stored at in buffer AE at 
-2O0C. 
Transfer of pure DNA into XL1-Blue competent cells 
Plasmid pHN1910, encoding an amino-terminal histidine-tagged version of the 
hTdpl protein sequence, was transformed into competent cells. XL1-Blue competent 
cells are usually the strain of choice for preparation of high-quality plasmid DNA. For 
our transfer experiment, 30 pl cells were thawed on ice. 1 pl of DNA purified from non- 
competent cells was directly pipetted into the competent cells and mixed by tapping 
gently. The vial was incubated on ice for 5 minutes and then incubated for exactly 30 
seconds in a 42°C water bath without mixing or shaking. The vial was removed from the 
bath and placed on ice. To this mixture, 250 pl of pre-warmed SOC medium (2% 
tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KC1, 10 mM MgC12, 10 rnM MgS04 
and 20 mM glucose) was added. SOC is a rich medium and therefore sterile technique 
was practiced to avoid contamination. The vial was placed in a microcentrifuge rack on 
its side and secured with tape to avoid loss of the vial. The vial was then incubated at 
37OC for exactly 1 hour in a shaking water bath set at 225 rpm. After incubation, 200 pl 
of the mixture from the vial was spread onto an agar plate pre-treated with 25 mgml 
ampicillin. In order to obtain well-spaced colonies, 1 pl of the mixture was diluted 1 : 100 
with LB medium and then spread on another ampicillin pre-treated agar plate. The plates 
were inverted and incubated at 37OC overnight. The next day a single colony was selected 
and inoculated into 6 ml LB medium and grown overnight at 37 OC. The overnight 
culture should turn turbid. 1 ml of this overnight culture was then added into I L LB 
medium (1 : 1000 dilution), which was pre-treated with 25 mg/ml ampicillin, and grown 
with vigorous shaking at 37 OC for at least 6 hours. Once turbidity starts to show, an 
aliquot was removed and the optical density (OD) checked at 600 nm, using LB (with no 
cells but antibiotic) as a blank. Once the required OD of 0.8- 1.0 has been reached, IPTG 
(isopropyl-p-D-thiogalactopyranoside) was added to a final concentration of 1 rnM. IPTG 
is a non-metabolisable artificial inducer of the lac operon. As a lac operon inducer, IPTG 
has been successfully used to increase the production of recombinant proteins produced 
in E. coli. The culture was allowed to shake vigorously at 37 OC for at least 2 hours. Cells 
were then pelleted by centrifugation at 4000 x g for 20 minutes at 4 O C  and resuspended 
in buffer containing 20 mM sodium phosphate, pH 7.4. The cell suspension was then 
sonicated in order to lyse the cells and this suspension was used for purification of 
recombinant enzyme. 
Recombinant hTdpl was purified using HiTrap Nickel Chelating columns. 
HiTrap Chelating, when charged with ~ i + ~  ions, will selectively bind proteins if complex- 
forming amino acid residues, in particular histidine, are exposed on the surface of 
proteins, e.g. poly-histidine tagged recombinant proteins. Proteins can be purified directly 
from bacterial lysates and are recovered from the matrix under mild elution conditions, 
using imidazole, which preserve antigenicity and functionality of the protein. The 
properties of the matrix give the opportunity to perform a complete purification in just 
10-1 5 minutes maintaining high selectivity and binding capacity. No special equipment is 
required, just a syringe is enough to perform purification. A HiTrap Chelating HP 1 ml 
column was used for our purification procedure. Prior to use, the column was pre-washed 
with 5 ml of distilled water using a syringe. For charging with ion, the column was then 
loaded with 0.5 ml of 0.1 M NiS04 in distilled water. The column was then washed a 
second time with 5 ml distilled water to remove any unbound metal ions. Once the 
sonicated cell suspension containing the recombinant protein was loaded, the columns 
was washed with 5 ml binding buffer containing 0.02 M sodium phosphate, 0.5 M NaCl 
and 5 mM imidazole, pH 7.4. Recombinant enzyme was eluted using 5 ml of elution 
buffer containing 0.02 M sodium phosphate, 0.5 M NaCl and 0.5 M imidazole, pH 7.4. 
The eluted protein was stored at 4OC. 
Cloning of Tdpl gene into pFLAGCMV2 human expression vector 
pFLAG-CMV2 human expression vector consists of a FLAG epitope tag that 
provides a method to localize gene products in living cells, identifl associated proteins, 
track the movement of tagged proteins within a cell, and characterize new genes without 
creating protein-specific antibodies. Previously, the full length coding sequence of human 
Tdpl was PCR-amplified and cloned into the BamHI sites of the PET-1 5b expression 
vector4', which adds a His-tag and a thrombin cleavage site to the N-terminus of Tdpl 
and then transformed into E.coli. This PET-Tdpl plasmid was cut with BsffiI restriction 
enzyme; the gap filled in and then again cut with BamHI restriction enzyme to release the 
Tdpl gene. The gene was then cloned within the Bgl II and EcoRV sites of the pFLAG- 
CMV2 vector and the ends ligated with the help of ligase at 16OC for 16 hours. A 0.8% 
agarose gel was run to check for correct ligation. 
Transient Transfection of FLAGTdpl and Untagged-Tdpl into 293B embryonic 
kidney cells 
Cells were seeded in 10 ml D-MEMJF-12 media from Life Technologies in 
150mm dishes until 80% confluence was reached on the day of transfection. Cells were 
incubated under normal growth conditions (37°C and 5% C 0 2 ) .  On the day of 
transfection, a total of 25 pg DNA (FLAG-tagged Tdpl or Untagged-Tdpl) for 5 plates 
(5 pg/ plate), dissolved in TE buffer, was diluted with cell growth medium (D-MEME- 
12) containing no serum, proteins, or antibiotics to a total volume of 750 pl. The solution 
was mixed and spun down for a few seconds to remove drops from the top of the tube. 
150 fl of SuperFect Transfection Reagent, purchased from Qiagen, was added to the 
DNA solution and mixed by pipetting up and down 5 times, or by vortexing for 
1 Oseconds. The samples were incubated for 5- 10 minutes at room temperature to allow 
transfection-complex formation. While the complex formation was taking place, the 
growth medium from the 150 rnm dishes was gently aspirated and the cells were washed 
once with 10 ml PBS. 7.5ml of D-MEMfF- 12 medium containing serum and antibiotics 
was added to the reaction tube containing the transfection complexes, mixed by pipetting 
up and down twice, and immediately transferred to the cells in the 150 rnm dishes. Cells 
were incubated with the transfection complexes for 2-3 hours on a rotating platform 
under their normal growth conditions. At the end of the incubation time, the medium 
containing the remaining complexes was removed by gentle aspiration and fresh cell 
growth medium containing serum and antibiotics was then added to the dishes and cells 
incubated for 48-72 hours before purification of Tdpl . 
Purification of recombinant Tdpl protein by Pull-down with Flag Beads and elution 
with Flag Peptide (by detergent) 
Extracts were prepared by first washing recombinant Tdpl transfected 293B cells 
from five 150 mm plates, with ice-cold PBS extensively. 4 ml of lysis buffer (10 mM 
Hepes, 60 mM KC1,l mM EDTA, 0.5% NP-40,0.5 mM PMSF, 0.5 mM DTT, 1 10 rnM 
NaN04, 0.5 pgml leupeptin, 0.5 pgml pepstatin) was added and cells were lysed on ice 
for 10 minutes. Lysed cells were spun at 2000 rpm for 5 minutes and the pellet containing 
nuclei was saved. The supernatant was re-spun for 10 minutes at 14000 rpm. After 
centrifugation, 4 ml TE (10 mM Tris-HC1,O.l mM EDTA; pH 8.0) containing protease 
inhibitors (PMSF, leupeptin, aprotinin, pepstatin) and 80-120 pl of Flag beads (washed 
with PBS) were added to the supernatant and the reaction incubated at 4OC on a rotating 
platform for 3 hours. The reaction was spun at 5000 rpm for 6 minutes. The beads were 
subjected to different washes containing 1X TE alone or 1X TE and 0.15 M NaCl or 0.5 
M NaCl or 1 M NaCl or 0.5 M LiCl or a combination of 1X TE, 0.1 5 M NaCl and 1 % 
Triton or 1X TX, 1 M NaCl and 1 % Triton or 1X TX, 0.5 M LiCl and 1 % Triton. Beads 
washed twice with 1 ml 1X TE containing protease inhibitors followed by washing twice 
with 1 ml TE containing PMSF only were subjected to western blot analyses to look for 
the co-precipitation of either XRCCl or Ku with Tdpl. Beads subjected to washes with 
different salt concentrations followed by washing twice with 1 ml 1X TE containing 
PMSF were subjected to western blot analyses to look for presence of purified Tdpl 
alone. After washing, 200 pl TE containing PMSF, 8 pl Flag peptide (Sigma, stock no.- 
F3290, concentration-4 mg) and 1 pl 100 pM DTT were added to the beads and 
incubated on a shaker at 1200 rpm overnight at 4°C. The reaction was spun at 5000 rprn 
for 6 minutes and 20% v/v of glycerol was added to the supernatant. Purified Flag-tagged 
Tdpl was then stored at -20°C. 
Purification of recombinant Tdpl protein by Pull-down with Flag Beads and elution 
with Flag Peptide (by dounce homogenization) 
Extracts were prepared by washing recombinant Tdpl transfected 293B cells from 
five 150 rnrn plates, with ice-cold PBS three times and once in ice-cold hypotonic lysis 
buffer containing 10 mM Tris-HC1; pH 8.0, 1 mM EDTA and 5 mM DTT. Cells were 
resuspended in 2 volume of hypotonic lysis buffer for 20 minutes at O°C. Cells were then 
lysed by dounce homogenization (- 20 strokes with a pestle). To the lysed cells, protease 
inhibitors (PMSF, leupeptin, aprotinin, pepstatin) were added and incubated for 20 
minutes on ice, following which high salt buffer containing 50 m M  Tris-HC1; pH 7.5, 1 
M KC1,2 mM EDTA and 2 mM D m  was added. The extract was centrifbged for 1 hour 
at 15000 rpm and the supernatant was dialyzed over night against E buffer (20 mM Tris- 
HC1; pH 8.0,O.l M KOAc, 20% voVvol glycerol, 0.5 rnM EDTA and 1 mM D m .  The 
next day, 4 ml TE (1 0 mM Tris-HC1,O. 1 mM EDTA; pH 8.0) containing protease 
inhibitors (PMSF, leupeptin, aprotinin, pepstatin) and 80-120 pl of Flag beads (washed 
with PBS) were added to the supernatant and the reaction incubated at 4°C on a rotating 
platform for 3 hours. The reaction was spun at 5000 rpm for 6 minutes. The beads were 
washed twice with 1 ml TE containing protease inhibitors and twice with 1 ml TE 
containing PMSF only. After washing, 200 pl TE containing PMSF, 8 pl Flag peptide 
and 1 pllO0 pM DTT were added to the beads and incubated on a shaker at 1200 rpm 
overnight at 4OC. The reaction was spun at 5000 rpm for 6 minutes and 20% vlv of 
glycerol was added to the supernatant. Purified Flag-tagged Tdpl was then stored at - 
20°C. 
Whole-cell extract preparation from lymphoblastoid cells obtained from SCAN1 
patients (JRL1, JRL3, JRL4), from unaffected relatives (JRL2, JRLS) and from 
known heterozygous carriers (JRL6, JRL7). 
The various cell-lines were obtained from Dr. James Lupski, Baylor 
University. Whole-cell extracts were prepared by growing cells in suspension culture 
using RPMI 1640 medium containing 10% FCS until a cell density of 2.5 to 5.0 x 1 o5 
cellslml was reached. After extensive washing with PBS, the cells were incubated in 2 
volume (pellet volume) hypotonic buffer (10mM Tris-HC1 (pH 7.0), IrnM EDTA, 5 m M  
DTT) for 20 minutes at O°C to induce cell swelling. The cells were subjected to 
mechanical shearing by the use of a Dounce homogenizer. Afier 10-20 strokes, protease 
inhibitors (PMSF, leupeptin, pepstatin) were added and incubated for 20 minutes on ice. 
0.5 volume high salt buffer (50mM Tris-HC1 (pH 7.5), 1M KCl, 2mM EDTA, 2mM 
DTT) was added and centrifuged for 1 hour at 15000rpm. The supernatant was subjected 
to overnight dialysis at 4OC with E-buffer (20mM Tris-HC1 (pH 8.0), 0.1M KOAc, 20% 
V/V glycerol, 0.5mM EDTA, ImM DTT). Following dialysis, the extract was aliquoted 
and fast-fkozen using liquid nitrogen to be stored at -70°C. 
Gel Filtration Chromatography and end-processing assays with GM00558B 
fractions 
Gel filtration was performed using a pre-packed 1.6 cm x 60 cm (1 90 ml bed 
volume) Sephacryl S-300 column (Pharmacia). The column was set up in the cold room 
and pre-washed with 2 column volumes (120 ml) of end-joining buffer (50 mM 
triethanolamine HC1160 mM KOAcl 0.5 mM magnesium acetate1 2 rnM ATPI 1 mM 
Dm1 100 pglml BSA). Glycerol was omitted fiom the end-joining buffer in order to 
reduce column flow pressure and facilitate column flow. The column was connected to a 
peristaltic pump whose rate was set such that 1 ml fractions were collected every seven 
minutes. Degassed and filtered buffer was pumped through the column. Prior to loading 
the extract, a standard curve was obtained using molecular weight markers (Bio-Rad) 
ranging fiom 1.7 kDa to 650,000 kDa. Five peaks corresponding to five different color- 
coded markers were recorded. Next, the column was again washed with 1 column volume 
of end-joining buffer before loading the extract. 1 ml of undiluted human lymphoblastoid 
cell extract (10 mglml) was thawed at 37OC for 5 minutes followed by 
microcentrifugation at 10,000 rpm for 5 minutes to remove any debris in the extract. 
Debris-free extract was then loaded onto the column and elution buffer containing 20 
mM Tris-HC1, pH 7.51 0.1 M KOAcI 0.5 mM EDTAI 1 mM D m ,  2 mM ATPI and 100 
pglml BSA was applied with a peristaltic pump at 0.14 mllmin. was recorded and 2 
ml fractions were collected overnight and stored at 4OC. 
End-processing assays with the fractions (10 pl) showing peak-enzyme activities 
were performed using 6 pl of each fraction in buffer containing 20 mM triethanolamine- 
HC1, pH 7.51 60 mM KOAcI 0.5 mM magnesium acetate1 2 mM ATPI 1 mM D?T/ 100 
pglml BSA and 20% (vlv) glycerol. The reaction buffer contained 0.5 rnM EDTA, and 
therefore the magnesium acetate concentration in the reactions was adjusted so that the 
final fi-ee M ~ + ~  concentration would be 0.5 mM. In some experiments M ~ + ~  was 
completely eliminated and instead, various concentrations of EDTA were used. 20 fino1 
of 3'-PG ss-14 mer or 3'-phosphotyrosine ss-18 were used for the reactions. Following 
incubation at 37OC for 2 hours, the oligomeric substrate was diluted with one volume of 
formamide containing 40 mM EDTA and electrophoresed on 20% denaturing 
polyacrylarnide-sequencing gels. Phosphorimages were analyzed with ImageQuant 3.3 
(molecular dynamics). 
End-processing assays of a double-stranded substrate with a 3'-PG overhang by Ku, 
DNA-PK and XRCC4-ligase IV. 
A double-stranded substrate with a 3'-PG overhang was pre-incubated with 
various dilutions of recombinant Ku or Ku-DNA-PK complex for 5 minutes at 25 OC to 
allow binding to the open end of the substrate followed by incubation with a 1 :5 12 
dilution (0.098 ng) of hTdpl (diluted using Pouliot dilution buffer containing 50 mM 
Tris-HC1, pH 8.01 5 mM D W  100 mM NaCll 5 mM EDTN 10% glycerol1 500 pdml 
BSA) for 10 minutes at 37 "C to allow PG-processing. If XRCC4-ligase IV was to be 
added, it was added after pre-incubation with the Ku-DNA-PK complex and before 
addition of Tdpl (and pre-incubated for 5 minutes at 25°C). End-processing assays of the 
double-stranded substrate with a 3'-PG overhang by Ku were carried out in Kedar buffer 
containing 20 mM triethanolamine-HCl, pH 7.51 60 mM KOAcl 0.5 mM magnesium 
acetate1 2 mM ATPI 1 mM DTTI 100 pglml BSA and 20% (vlv) glycerol. 3 M sodium 
acetate and 1 mdml tRNA were added to final concentrations and samples were then 
subjected to phenollchloroform extraction. After extraction of Ku, samples were 
dissolved in 1X TE. NEB buffer 4 and 40 Wml  PNKP were added and samples 
incubated for 1 hour at 37 "C. M ~ + ~  was not added separately as it was already present in 
the reaction buffer. AvaI was added and samples were incubated for 3 hours at 37 "C to 
yield a 15-mer with the 3'-OH. The samples were then electrophoresed on 20% 
denaturing polyacrylamide-sequencing gels. Phosphorimages were analyzed with 
IrnageQuant 3.3 (molecular dynamics). 
. End-processing assays consisting of DNA-PK alone, Ku-DNA-PK complex and 
Ku-DNA-PK-XRCC4fligaseIV complex were carried out in Ramsden buffer containing 
25 mM Tris-HC1, pH 7-51 50 pglml BSN 45 mM KC11 105 mM NaCV 0.05% Triton X- 
1001 0.1 mM EDTN 2 mM DTT. If the Ramsden buffer was used, 0 .2~1 of a mixture of 
100pM ATP and 5 mM MgC12 was added as required along with the hTdpl . For 
experiments conducted without ATP, MgC12 was also not added. Following boiling of the 
samples at 90°C for 2 minutes, the substrate was incubated with 1 pl of 1000 units1 mL 
alkaline phosphatase (CP) for 1 hour at 37OC for removal of 3'-terminal phosphate 
group. The samples were again heated at 90°C for 5 minutes and then incubated with 1 pl 
TaqaI (20,000 unitslml) for 3 hours at 65°C to yield a 15-mer with the 3'-OH. The 
samples were then electrophoresed on 20% denaturing polyacrylamide-sequencing gels. 
Phosphorimages were analyzed with ImageQuant 3.3 (molecular dynamics). 
Western Blotting 
10% SDS-polyacrylamide gels were used for western blotting. A large and a 
small glass plate were cleaned with 70% ethanol and dried with kim-wipes and aligned in 
a gel caster. Resolving gel (20ml) was prepared with 8.8 mL milliQ water1 4.2 mL1.5 M 
Tris-HC1, pH 8.81 6.6 mL 30% acrylamidel166 pL 10% SDSJ 166 pL 10% ammonium 
persulfate and 67 pL TEMED. Stacking gel (3 mL) was prepared with 2.1 mL milliQ 
water/ 0.5 mL 30% acrylamide/ 0.38 mL 1 M Tris-HC1, pH 6.81 30 pL 10% SDS/ 30 pL 
10% ammonium persulfate and 3 pL TEMED. 10 pl aliquots of whole-cell extracts or 
purified Tdpl were mixed with 2 p15X sample buffer containing 1 M Tris, pH 6.81 5 % 
glycerol/ 10% SDSI 5 % P-mercaptoethanoV 2% bromophenyl blue, denatured by boiling 
for 5 minutes and electrophoresed on the 10% SDS-polyacrylamide gel in running buffer 
containing 25 mM Tris base/ 250 mM glycine and 0.1 % SDS. Electrophoresis was 
carried out at 100V for the first 8 minutes followed by 200V for the next 40 minutes. The 
gel was removed and the stacking gel cut off. The resolving gel was then put into transfer 
buffer containing 25 mM tris base1 192 mM glycine and 20% methanol. The 'transfer 
sandwich' was assembled fiom the black side of the cassette to the white side with 
sponge, Whatman filter paper, the gel followed by nitrocellulose membrane followed 
again by Whatman filter paper and finally by another sponge. The sandwich was put into 
the transfer box, black side to back. A spacer pack frozen at -20°C was also put into the 
transfer box. Transfer buffer was poured in and the transfer was carried out at 100V for 
-2 hours. Following transfer, the nitrocellulose membrane was stained with Ponceau S 
stain to check for completion of transfer. The dye was rinsed off with distilled water and 
the membrane was transferred into blotto solution made up of 10 rnM Tris, pH 7.4, NaCl 
and 5% non-fat dry milk. The membrane was blocked in blotto overnight at 4OC with 
continuous rocking. Next day, the respective primary antibodies were mixed in fresh 
blotto (Table 1). Incubation with primary antibody was carried out at room temperature 
for -2 hours with continuous rocking. The primary antibodies were washed off twice 
using 20 mL Blotto wash containing 0.05% Nonidet P-40 and 1X PBS. Each wash was 
carried out for 15 minutes. The membrane was then incubated with the required 
secondary antibody for 1 hour at room temperature. The blot was then subjected to two 
washes, each for 15 minutes, with 20 mL Tris-Buffered Saline (TBS)-Tween 20. For 
cherni-luminescence, 500 pl of each of the two super signal solutions (Pierce, Rockford, 
IL) were mixed and the blot was exposed to the solution for about 1 minute followed by 
autoradiography. 
TABLE 1. 
INCUBATION 
PRIMARY 
ANTIBODY 
Rabbit anti- 
hTdp 1 
(Abcarn Inc.; 
Cat No.- 
DILUTION 
- USED 
1 : 1000 
VOLUMES 
- FOR 
INCUBATION 
10 pl in 10 
rnL 
ab4 166) 
Mouse Anti- 
10 pl in 10 
(NeoMarkers; 
Cat No.- MS- 
FLAG 
(Sigma; Cat 
NO.- F-3 165) 
Rabbit anti- 
Ku 70 
SECONDARY 
ANTIBODY 
Goat anti- 
rabbit 
1 :2000 
1 :2000 
XRcc4 
(GeneTex, 
Inc.; Cat No.- 
DILUTION 
- USED 
1 : 10,000 
5 N i n 1 0  
(Serotec Inc.; 
Cat No.- 
AHP3 16) 
434-PI) 
Rabbit anti- 
Goat anti- 
rabbit 
1 : 1000 
l:lO,OOO 1 i n  10 1 
10 pl in 10 
mL 
: Goat anti- 
rabbit 
1:10,000 1 pl in 10 
mL 
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                                                           Results 
 
 
Tyrosyl-DNA phosphodiesterase (Tdp1) is capable of removing glycolate from 3′-PG 
overhangs. 
Tdp1 is the only enzyme known so far to convert any 3′-blocked termini to 3′-
phosphates. The first report of an activity that cleaves a 3′-tyrosyl-phosphodiester bond 
was reported in 1996. Using column chromatography, Yang et al partially purified this 
activity from crude extracts of budding yeast S. cerevisiae as a ~55 kDa enzyme 
independent of any cofactor requirement to function. The enzyme specifically cleaved the 
phosphodiester bond that connected the 3′-end of DNA to a tyrosine in the active site of 
topoisomerase I enzyme, thus liberating a 3′-phosphate ended DNA molecule (Yang et 
al., 1996). Such linkages are formed as intermediates during DNA relaxation by 
topoisomerase I, and in DNA cleavage and reunion by various recombinases. These 
intermediates can become trapped if the process is interrupted, e.g., by a topisomerase 
inhibitor or by collision with a replication fork. The hypersensitivity of tdp1 mutant yeast 
to topoisomerase I-mediated DNA damage (Pouliot et al., 1999) suggests a critical role 
for scTdp1 in repair of such lesions. Later, a gene (TDP1) encoding this enzyme was 
identified in yeast, which was conserved in eukaryotes. Analysis of single and double 
mutants of TDP1 and RAD52 suggests that both belong to the same epistasis group while 
TDP1 and RAD9 belong to different groups (Pouliot et al., 2001). A human homologue 
with similar 3′-phosphotyrosyl- processing activity, hTdp1, was cloned by homology to 
scTdp1 and was eventually shown to have some homology to the phospholipase D (PLD) 
superfamily of phosphodisterases (Interthal et al., 2001). Yeast and human Tdp1 differ 
from other activities for processing blocked 3′ ends in that they leave a 3′-phosphate  
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Figure 1: 3'-PG (·) and 3'-phosphotyrosine (p-Tyr) substrates. 
 
The 3'-PG oligomers were prepared by bleomycin treatment of partial duplexes. 
* indicate the site of the 32P label. The plasmid substrate is 5.5kb in length. 
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Figure 1 
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Figure 2: Conversion of 3'-phosphotyrosine termini to 3'-phosphate termini by 
native hTdp1. 
 
20fmol of 3'-phosphotyrosine 18-mer was treated with 6µl Sephacryl fractions 20-40 
from human whole-cell extracts in Kedar buffer containing 20 mM triethanolamine-HCl, 
pH 7.5/ 60 mM KOAc/ 5 mM EDTA/ 2 mM ATP/ 1 mM DTT/ 100 µg/ml BSA and 20% 
(v/v) glycerol. Samples were incubated for 2 hours at 37°C and conversion to 3'-
phosphate was assessed by denaturing gel electrophoresis. Fractions 27-30 showed 100% 
conversion to 3'-phosphate. 
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Figure 2 
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rather than a 3′-hydroxyl. To determine whether the activity for removal of glycolate 
from single-stranded 3′-PG termini in human cell extracts might be hTdp1, we 
fractionated extracts by gel filteration chromatography on Sephacryl S-300 (Inamdar et 
al., 2002). A prominent peak of glycolate-removing activity was found to colelute with 
hTdp1 protein as detected with hTdp1 antiserum at a position approximately midway 
between the 44- and 158-kDa markers. In the presence of EDTA, this fraction was found 
to catalyze the 3′-PG-to-3′-phosphate conversion with no detectable formation of 3′-
hydroxyl (Figure 3).  
No evidence of multiple forms of the enzyme separable by the sephacryl column 
Previously in our laboratory, titration of the activity in the peak fraction showed 
that it processed a 3′-phosphotyrosine oligomer 8-fold more efficiently than a plasmid 
containing PG-terminated 3′-overhang (Figure 4), consistent with its identification as 
hTdp1 (Inamdar et al., 2002). However, the peak of PG-processing activity seemed to be 
slightly shifted from the peak of hTdp1 as detected with an antibody, raising the 
possibility of multiple forms with differing PG-processing efficiencies. To determine 
whether this difference in processing efficiencies was due to the presence of different 
splice forms of hTdp1, we duplicated the above experiment and four fractions showing 
peak activity were chosen. The plasmid containing the 3′-PG terminated single-strand 
overhang was replaced by a 3′-PG containing 14-mer. Titration experiments using each 
of the 4 fractions showed that hTdp1 processed the 3′-phosphotyrosine containing 18-mer 
10-fold more efficiently than the 3′-PG containing 14-mer (Figure 5). Since the Sephacryl 
S-300 column separates different fractions based on size, we conclude that there was no 
evidence of splice variants or other multiple forms of the enzyme. 
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Figure 3: Conversion of 3'-PG termini to 3'-phosphate termini by native hTdp1. 
 
20 fmol of 3'-PG 14-mer was treated with 6µl Sephacryl fractions 24-35 in Kedar buffer 
containing 20 mM triethanolamine-HCl, pH 7.5/ 60 mM KOAc/ 5 mM EDTA/ 2 mM 
ATP/ 1 mM DTT/ 100 µg/ml BSA and 20% (v/v) glycerol. Samples (a total volume of 10 
µl) were incubated for 2 hours at 37°C and conversion to 3'-phosphate was assessed by 
denaturing gel electrophoresis.  
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Figure 3 
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Figure 4: Relative efficiency of native end-processing activities 
A 3'-phosphotyrosine 18-mer (▲) or a plasmid with a PG-terminated 3'-overhang (●) 
was treated with 4 µl of undiluted, followed by 1 µl of seven 1:4 dilutions of sephacryl 
fraction 30 from human whole-cell extracts. Each substrate was incubated at 37 ºC for 2 
hours in Kedar buffer containing 5 mM EDTA and no MgP2+  P(see Fig. 2). Conversion to 
3'-phosphate was assessed by denaturing gel electrophoresis and quantified using 
ImageQuant software. The difference in relative end-processing efficiency was found to 
be approximately 8-fold. 
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Figure 4 
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Figure 5: Relative efficiencies of native end-processing activities. 
 
A 3'-phosphotyrosine 18-mer (○) or a 3'-PG 14-mer (●) was treated with 4 µl of 
undiluted, followed by 1 µl of seven 1:4 dilutions of  sephacryl fractions 27-30. Each 
substrate was incubated at 37 ºC for 2 hours in Kedar buffer containing 5 mM EDTA and 
no MgP2+P. Conversion to 3'-phosphate was assessed by denaturing gel electrophoresis and 
quantified using ImageQuant software. The difference in end-processing efficiencies 
between the two substrates was found to be approximately 10-fold in each of the four 
fractions. 
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Figure 5 
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Processing efficiency of scTdp1 is affected by various factors 
 Previously, experiments using scTdp1 showed that, compared with its hydrolysis 
of a 3′-phosphotyrosine residue, scTdp1 or yTdp1 removed 3′-PG very inefficiently 
(Pouliot et al., 2002). When a mixture containing roughly equimolar amounts of an 18-
mer containing 3′-phosphotyrosine and a 21-mer containing 3′-PG was incubated with 
scTdp1 at 30°C for 20 minutes in buffer without EDTA, the 21-mer terminating in 3′-PG 
required at least a 50-fold higher concentration of the enzyme to achieve a comparable 
initial rate and at least a 100-fold increase in concentration to achieve a 50% conversion 
rate. Based on these results, our laboratory decided to compare the processing efficiencies 
of an 18-mer containing 3′-terminal phosphotyrosine with a 14-mer containing a terminal 
3′-PG and a 19-mer containing a 3′-PG. In comparison to the experimental conditions 
used by Pouliot et al., we incubated the substrates with the recombinant scTdp1 for 2 
hours at 37°C in buffer containing EDTA (as was carried out by our laboratory with 
hTdp1). The results showed that under these conditions, the difference between the 
processing efficiencies of the 18-mer with 3′-phosphotyrosine and the 3′-PG containing 
substrates was lesser (~ 10-fold) and both the 14-mer and the 19-mer containing terminal 
3′-PG achieved 50% conversion of the substrate with approximately the same 
concentration of the enzyme suggesting that the size of the substrate did not affect the 
processing efficiency of recombinant yeast Tdp1 (Figure 6a). We next conducted two sets 
of experiments in which one set containing a mixture of the 18-mer with 
phosphotyrosine, 14-mer with 3′-PG and the 19-mer with 3′-PG was incubated with 
scTdp1 for 20 minutes at 30°C, heated for 1 minute at 90°C, treated with 20 ng hPNKP, 
again incubated for 1 hour at 37°C and electrophoresed on a denaturing polyacrylamide 
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gel. hPNKP, a MgP+2 Pdependent enzyme, was added for conversion of 3′-phosphate to 3′-
OH which separates much better from 3′-PG on sequencing gels . The second set 
consisted of a mixture of another 19-mer with terminal 3′-PG and scTdp1 supplemented 
with 20 ng hPNKP that was incubated for 20 minutes at 30°C, heated for 1 minute at 
90°C and then electrophoresed on a denaturing polyacrylamide gel. Both the sets of 
reactions were carried out in buffer containing a final concentration of 0.5 mM MgCl B2 
Band without EDTA. Our results showed that under these different conditions, the 18-mer 
with terminal 3′-phosphotyrosine was processed ~20-fold more efficiently than the 14-
mer containing terminal 3′-PG (when compared to the ~ 10-fold difference in our 
previous experiment). Also, there was at least an 8-fold difference in the processing 
efficiencies between the 14-mer and 19-mer 3′-PG substrates making the processing 
difference between the 3′-tyrosine substrate and 3′-PG containing 19-mer ~100-fold 
(Figure 6b). All these data suggested that the relative efficiency of the yeast enzyme was 
affected by different experimental conditions such as temperature and time of incubation. 
It was shown previously that both human and yeast recombinant enzymes converted 3′-
PG termini to 3′-phosphate termini in either the presence or absence of Mg P+2 P(Inamdar et 
al., 2002). However, omitting EDTA from the buffer and adding MgP+2 Pin our experiments 
was also found to affect the activity of scTdp1. The combination of buffer, temperature 
and oligo length effects can explain the apparent disparity between our results (Inamdar 
et al., 2002) and results from Pouliot et al. (2002). 
Recombinant human Tdp1 shows relatively lower 3′-PG removal activity than 
partially purified native hTdp1 
 
  57   
 
 
 
 
 
 
 
Figure 6: Relative end-processing efficiencies of recombinant scTdp1. 
 
6a- 28, 7, 1.75, 0.44, 0.11, 0.027, 0.0068 or 0.0017 ng of recombinant yeast Tdp1 was 
incubated with 3’-phosphotyrosine 18-mer (■) or a 3’-PG 14-mer (▲) or a 3’-PG 19-mer 
(♦) in end-joining Kedar buffer containing EDTA for 2 hours at 37 °C. Conversion to 3’-
phosphate was analyzed by PAGE and results were quantified using ImageQuant 
software.  
 
6b- 28, 7, 1.75, 0.44, 0.11, 0.027, 0.0068 or 0.0017 ng of recombinant yeast Tdp1 was 
treated with 3’-phosphotyrosine 18-mer (○) or a 3’-PG 14-mer (●) or a 3’-PG 19-mer 
(▲), incubated at 30 °C for 20 mins in Kedar buffer and heated at 90°C for 1 min. 20 ng 
of human PNKP was added and samples were incubated at 37°C for 1 hour and analyzed 
by gel electrophoresis. A second 19-mer with 3’-PG (∆) was treated with both yeast Tdp1 
and hPNKP together and incubated at 30 °C for 20 mins before being analyzed. EDTA 
was not present; instead a final concentration of 0.5 mM MgCl B2 Bwas added to the buffer. 
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Previously, experiments conducted to determine the efficiency of the processing 
of 3′-PG termini by hTdp1 using a 3′-phosphotyrosine DNA oligomer and a DSB 
substrate with a PG-terminated 3′-overhang treated with various concentrations of the 
recombinant His-tagged hTdp1, grown in E.coli, showed that the 3′-PG substrate required 
an ~80-fold greater concentration of recombinant hTdp1 for half-maximal conversion 
than did the 3′-phosphotyrosine oligomer, more than would have been expected based on 
the activities in fractionated extracts (Inamdar et al., 2002). This difference in relative 
preference for 3′ phosphotyrosine over 3′-PG substrates, 80-fold for purified recombinant 
hTdp1 versus 10-fold for native activity in extracts, raised the question of whether most 
of the native PG-processing activity might be attributable to some functionally similar but 
distinct enzyme. While this possibility has not been completely eliminated, it seems 
unlikely, as such an enzyme would have to precisely co-elute with hTdp1 from the 
Sephacryl S-300 column and would also have to cross-react with antibody against the 
recombinant hTdp1 to explain immunodepletion data observed previously (Inamdar et al., 
2002). To determine whether this difference in processing efficiencies was due to 
degradation of the enzyme (provided by Dr. Jeff Pouliot, NIMH) during its shipping 
and/or its freezing and thawing, we purified recombinant hTdp1 in our laboratory using 
Amersham Hi-Trap nickel chelating columns and repeated the experiment. Our results 
still showed a 100-fold difference in the processing activities (Figure 7) suggesting that 
the different substrate preferences may likely be attributable to other factors such as the 
presence of the histidine tag, interactions with other proteins in the fractionated extract 
that may enhance activity or differences in post-translational modification in human 
versus bacterial cells. 
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Figure 7: Relative end-processing efficiency of recombinant hTdp1 
A 3'-phosphotyrosine 18-mer (○) or a 3'-PG 14-mer (●) was treated with 4 µl of 
undiluted, followed by 1 µl of six 1:4 dilutions of recombinant His-tagged hTdp1, 
purified from E.coli. Each substrate was incubated at 37 ºC for 2 hours in Kedar buffer 
containing 5 mM EDTA and no MgP2+P. Conversion to 3'-phosphate was assessed by 
denaturing gel electrophoresis and quantified using ImageQuant software. The relative 
end-processing efficiency was found to be approximately 100-fold. 
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Figure 7 
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No evidence of the Flag peptide having any effect on the specificity of the enzyme 
To assure that hTdp1 has normal post-translational modification and also to avoid 
any inactivation due to exposure of the enzyme to the nickel column (as was seen with 
PNKP; M.Weinfeld, personal communication), our laboratory cloned the Tdp1 gene into 
the human expression vector, pFLAG-CMV2 (Figure 9). The pFLAG-CMV2 vector 
consists of a FLAG epitope tag that provides a method to localize gene products in living 
cells, identify associated proteins, track the movement of tagged proteins within a cell 
and characterize new genes without creating protein-specific antibodies. Untagged Tdp1 
was cloned into pCMV-M human expression vector and used as a negative control for 
our experiment. The pFLAG-CMV2 vector containing the cloned Tdp1 gene was 
transfected into 293B embryonic kidney cells, and overexpressed hTdp1 protein was 
purified using FLAG beads and eluted with FLAG peptide (Figures 11a and b). 
Untagged-Tdp1 was also cloned into pCMV-Tag1 human expression vector (Figure 10), 
transfected, purified and used as a negative control for our experiment. We carried out a 
western blot analysis that showed a high and approximately equal expression of Tdp1 in 
whole cell extracts from cells with both FLAG-tagged Tdp1 and Untagged-Tdp1. We 
also observed recovery of FLAG-tagged hTdp1 and no recovery of Untagged-hTdp1 after 
purification with FLAG beads suggesting that only the tagged protein was bound to and 
eluted from the beads as expected (Figure 11c). When the processing efficiencies of 
whole cell extracts containing either FLAG-tagged Tdp1 or Untagged-Tdp1 were 
compared, we observed about the same 100-fold difference in processing efficiencies for 
3'-PG and 3'-phosphotyrosine oligomers as with recombinant hTdp1 purified from Hi- 
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Figure 8: The pET-15b E.coli vector; the source for His-tagged Tdp1 gene. 
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Figure 8 
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Figure 9a: The pFLAG-CMV2 human expression vector used for cloning Tdp1 gene. 
 
Figure 9b: Protocol for cloning. 
Tdp1 insert was excised from pET 15-Tdp1 as a Bam HI-BsrGI fragment, filled in with 
BsrGI and cloned into the BglII and EcoRV sites of the vector to give rise to a plasmid 
encoding FLAG-tagged Tdp1, designated as pCMV-FLAG-Tdp1. 
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Figure 9a 
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Figure 9b 
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Figure 10: The pCMV-Tag1 human expression vector used for cloning Tdp1 gene.  
 
Flag and c-myc epitopes were removed. Within the Tdp1 insert a pyrimidine at –3 
position to an ATG sequence was replaced with a purine to ensure normal translation. 
The product formed was untagged Tdp1 which was used as a negative control. 
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Figure 10 
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Protein gel using silver staining 
 
A protein gel was carried out to estimate the concentration of FLAG-hTdp1 purified by 
dounce homogenization and by using detergent from both pFLAG-Tdp1 transfected 293B 
human embryonic kidney cells and from adenovirus infected U-87 glioma cells. 30, 100, 
300, 1000 or 3000 ng of BSA was loaded onto separate wells as controls.  
11a: The last 4 wells contain 2 µl of FLAG-hTdp1 purified using detergent from U-87 
cells, 5 µl and 2 µl of FLAG-hTdp1 purified using dounce homogenization from 293B 
cells and 2 µl of FLAG-hTdp1 purified using detergent from 293B cells respectively. 
11b: The last 4 wells contain 2 µl of FLAG-hTdp1 from 293B cells, 4 µl of micro-
dialyzed hTdp1, 4 µl each of 1st and 2nd hTdp1 elutions from U-87 cells. Each of these 
samples was purified using 0.5% NP-40. 
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Figure 11a 
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Figure 11c: Western Blot analysis of whole-cell and purified extracts 
 
A western (using Mouse anti-FLAG antibody) was carried out with samples containing 
0.2 µl and 1µl whole-cell extracts containing FLAG-tagged hTdp1, 0.2 µl whole-cell 
extract containing untagged hTdp1, 0.5 µl purified FLAG-hTdp1 and 0.5 µl untagged 
hTdp1. Equal concentration of hTdp1 was found in the whole-cell extracts containing 
FLAG-hTdp1 and untagged hTdp1. The sample containing purified FLAG-hTdp1 
showed a band while the sample containing purified untagged hTdp1 did not show a band 
proving that only FLAG-hTdp1 was purified using FLAG beads and FLAG peptide. 
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Figure 11c 
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Trap nickel chelating columns, suggesting that the FLAG tag has no effect on the potency 
or specificity of the enzyme (Figure 12). 
Better recovery of Tdp1 activity by NP-40 detergent lysis than by dounce 
homogenization 
 In our laboratory, pFLAG-Tdp1, along with Superfect transfection reagent, was 
transfected into 293B embryonic kidney cells. Following incubation for 3 days, the cells, 
instead of being dounced as per usual experimental procedure, were treated with lysis 
buffer containing Nonidet P-40 or NP-40 (a phenol-containing detergent) to lyse the cells 
and release their cytoplasmic contents. Protease inhibitors were added and FLAG-Tdp1 
was adsorbed onto FLAG beads and eluted with FLAG peptide. A protein gel using silver 
staining was carried out to compare the protein content in the extracts purified using 
dounce homogenization vs. extracts purified using 0.5% NP-40 (Figures 11a and b). 
When we compared the processing efficiencies of FLAG-Tdp1 obtained using detergent 
with that of FLAG-Tdp1 obtained via dounce homogenization, we observed that while 
the former retained the 100-fold difference between phosphotyrosyl and PG-substrates as 
seen with recombinant Tdp1 purified using Hi-Trap Nickel chelating columns, the latter 
hardly showed any PG-processing even at undiluted concentrations. These results lead us 
to use NP-40 for cell lysis rather than dounce homogenization while purifying FLAG-
Tdp1 (Figure 13). 
Relative processing efficiency of FLAG-hTdp1 cloned into an adenovirus was ~100-
fold 
The many differences between bacterial and human cells lead us to clone human 
FLAG-Tdp1 into an adenovirus and purify it from transduced human cells using FLAG  
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Figure 12: Relative end-processing efficiencies of FLAG-hTdp1 and Untagged 
hTdp1 
 
A 3'-phosphotyrosine 18-mer (○) or a 3'-PG 14-mer (●) was treated with 1 µl of undiluted 
or 1 µl of six 1:8 dilutions of extracts containing overexpressed FLAG-hTdp1 and 
Untagged hTdp1. Each 5µl reaction was incubated at 37 ºC for 2 hours in Kedar buffer 
containing 5 mM EDTA. Samples were boiled for 1 minute at 90 ºC. 20 mM Mg P2+ Pand 20 
ng hPNKP were added. Conversion to 3'-OH was assessed by denaturing gel 
electrophoresis and quantified using ImageQuant software. The difference in relative 
end-processing efficiencies was found to be approximately 100-fold. 
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Figure 12 
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Figure 13: To compare the end-processing efficiencies of FLAG-hTdp1 purified via 
dounce homogenization vs. FLAG-hTdp1 purified using 0.5% NP-40 
 
A 3'-phosphotyrosine 18-mer (○) or a 3'-PG 14-mer (●) was treated with 25, 3.125, 0.39, 
0.048, 0.0061, 0.00077, 0.000095 or 0.0000012 ng of FLAG-hTdp1 purified using 
dounce homogenization OR 50, 6.25, 0.78, 0.098, 0.012, 0.0015 or 0.0002 ng of FLAG-
hTdp1, purified using 0.5% NP-40. Each 5µl reaction was incubated at 37 ºC for 2 hours 
in Kedar buffer containing 5 mM EDTA. Samples were boiled for 1 minute at 90 ºC. A 
final concentration of 20 mM MgP2+ Pand 20 ng hPNKP were added. Conversion to 3'-OH 
was assessed by denaturing gel electrophoresis and quantified using ImageQuant 
software. Our results showed that the latter retained the 100-fold difference as seen with 
recombinant Tdp1 purified using Hi-Trap Nickel chelating columns, while the former 
hardly showed any PG-processing even at undiluted concentrations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  78   
 
Figure 13 
 
  
Via DOUNCE HOMEGENIZATION   
 
 
 
                  Via DETERGENT 
Log Dilution
1e-6 1e-5 1e-4 1e-3 1e-2 1e-1 1e+0
%
 c
on
ve
rs
io
n
0
20
40
60
80
100
Log Dilution
1e-7 1e-6 1e-5 1e-4 1e-3 1e-2 1e-1 1e+0 1e+1
%
 c
on
ve
rs
io
n
0
20
40
60
80
100
100-FOLD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  79   
 
beads and FLAG peptide. Once cloned, when the relative processing efficiency of FLAG-
tagged Tdp1 from purified adenovirus infected U87 glioma cells was compared, we 
observed about the same 100-fold difference in processing efficiencies for 3'-PG and 3'-
phosphotyrosine oligomers (Figures 14a and 14b) as with recombinant hTdp1 purified 
from bacteria using Hi-Trap nickel chelating columns, suggesting that if Tdp1 was post-
translationally modified in mammalian cells, these modifications did not have any effect 
on the specificity of the enzyme.  
Extracts of SCAN1 cells with mutant Tdp1 are deficient in PG-processing 
A possible theory regarding patients suffering from spinocellebelar ataxia with 
axonal neuropathy is that oxidative stress coupled with hTdp1 deficiency results in 
persistent 3'-phosphoglycolates resulting in persistent DSBs and neuronal apoptosis. To 
examine the molecular basis of SCAN1, blood samples were collected from 7 related 
individuals of an affected Saudi Arabian family and Epstein-Barr virus transformed 
lymphoblastoid cell lines were established by Dr. James Lupski. Upon receiving these 7 
cell lines, named JRL1-7 respectively, we prepared whole-cell extracts and tested 
dilutions of each extract for the processing of a 3'-phosphotyrosine containing 18-mer. 
We observed that while JRL-1 and JRL-3 extracts showed no conversion of 3'-
phosphotyrosine to 3'-phosphate, undiluted JRL -5, 6 and 7 extracts catalyzed complete 
conversion (Figure 15a). JRL-4 extract showed an extremely low conversion when 
undiluted and no conversion with subsequent dilutions. These results suggested that JRL-
1 and 3 extracts contained mutated hTdp1 while JRL-5, 6 and 7 extracts contained the 
wild-type hTdp1 and this was found to be in agreement with genetic and sequencing data; 
JRL-1,-3 and –4 are homozygous Tdp1 mutants, JRL-2 and –5 are normal while JRL-6  
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Figure 14a and 14b: Relative end-processing efficiency of FLAG-hTdp1 cloned into 
an adenovirus. 
 
A 3'-phosphotyrosine 18-mer (○) or a 3'-PG 14-mer (●) was treated with 50, 6.25, 0.78, 
0.098, 0.012, 0.0015 or 0.0002 ng of FLAG-hTdp1, purified from adenovirus infected U-
87 glioma cells. Each 5µl reaction was incubated at 37 ºC for 2 hours in Kedar buffer 
containing 5 mM EDTA. Samples were boiled for 1 minute at 90 ºC. A final 
concentration of 20 mM MgP2+ Pand 20 ng hPNKP were added. Conversion to 3'-OH was 
assessed by denaturing gel electrophoresis and quantified using ImageQuant software. 
The difference in relative end-processing efficiencies was found to be approximately 
100-fold. 
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and –7 are heterozygous carriers. To assess whether this mutation resulted in deficiency 
in 3'-PG processing, a 3'-PG containing14-mer was incubated with JRL-1, 5 and 6 
extracts (Figure 15b). In JRL-1 whole-cell extract, PG processing was undetectable while 
partial conversion to 3'-phosphate was seen in JRL-5 and JRL-6. This suggests that most, 
if not all 3'-PG processing activity in extracts is attributable to Tdp1. 
When the processing efficiencies of purified FLAG-tagged hTdp1 were compared 
in our previous experiments, we observed that the 3'-phosphotyrosyl-containing 18-mer 
was 100-fold more efficiently processed than the 3'-PG containing 14-mer. However, 
addition of whole-cell extracts from Tdp1-mutant, JRL-1, to purified FLAG-hTdp1 
reduced the ratio of phosphotyrosyl to PG processing activities from 100:1 to 10:1. Our 
results showed that the 3'-phosphotyrosine processing efficiency decreased while the 3'-
PG processing efficiency increased on addition of JRL-1 extract (Figure 15c). These 
results suggest that Tdp1 specificity is modulated by other factors in the whole-cell 
extract. 
No evidence for the presence of other Mg+2 –dependent PG-processing enzymes 
Since whole-cell extracts of Tdp1-mutant SCAN1 cells showed no detectable 
processing of 3'-PG-terminated oligomers, it was suggested that most, if not all, 3'-PG-
processing is attributable to Tdp1. However, these assays were conducted in the presence 
of 5mM EDTA in the reaction buffer in order to inhibit nucleases that would otherwise 
interfere with the detection of PG-processing activity of Tdp1. Mg+2 acts as a co-factor 
for most nucleases. In the presence of this EDTA, any Mg+2 added would form a chelate 
complex rendering it inaccessible to enzymes and therefore, Mg+2 –dependent PG-
processing enzymes, if present, would have been difficult to detect. In order to look for  
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Figure 15: Relative end-processing efficiencies of SCAN1 whole-cell extracts (JRL 1-
7) 
 
15a: An 18-mer containing 3’-phosphotyrosine was treated with 1 µl of undiluted, 
followed by 1 µl of two 1:8 dilutions of each of the seven JRL whole-cell extracts for 2 
hours at 37° C in Kedar buffer with EDTA and samples were analyzed by polyacrylamide 
gel electrophoresis. JRL 2, 5, 6 and 7 showed presence of wild-type hTdp1 while JRL 1, 
3 and 4 seemed to contain no 3’-phosphotyrosine processing activity, consistent with 
these cells harboring mutant hTdp1. JRL 4 also showed some residual activity. 
15b: An 14-mer containing 3’-PG was treated with 1 µl of undiluted, followed by 1 µl of 
four 1:8 dilutions of JRL whole-cell extracts-1, 5, and 6- for 2 hours at 37° C in Kedar 
buffer with EDTA and samples were analyzed by PAGE. JRL 5 and JRL 6 showed a 
partial conversion to 3’-phosphate at undiluted concentration. 
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Figure 15c. Effect of addition of JRL 1 whole-cell extract to purified FLAG-tagged 
hTdp1 
 
An 18-mer containing 3’-phosphotyrosine or a 14-mer containing 3’-PG was treated with 
50, 6.25, 0.78, 0.098, 0.012, 0.0015 or 0.0002 ng of FLAG-hTdp1, purified from 
adenovirus infected U-87 glioma cells. To another similar set, 1.8 µl of a 7mg/ml JRL 1 
whole-cell extract (containing mutated hTdp1) was added along with the FLAG-hTdp1 
and the substrate. Each set was incubated for 2 hours at 37° C in Kedar buffer with 
EDTA and no ATP. Samples were then analyzed by polyacrylamide gel electrophoresis. 
Our results showed that addition of JRL-1 whole-cell extract reduced the ratio of 
phosphotyrosyl to PG processing activities from 100:1 to 10:1 (also refer to Fig 14b). The 
3’-phosphotyrosine processing efficiency decreased while the 3’-PG processing 
efficiency increased suggesting that Tdp1 specificity is modulated by other factors in the 
whole-cell extract. 
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the presence of such enzymes, a phosphorothioate- substituted 3'-PG substrate that is 
nuclease-resistant was prepared in our laboratory. This thiolated oligo prevents 3'-> 5' 
exonucleases from degradaing the DNA end. The oligomer was incubated with different 
dilutions of JRL1 cells containing mutated Tdp1 in the presence of 100 mM Mg+2 and 
subsequently treated with PNKP. We did not observe any conversion of the 3'-
phosphotyrosyl and 3'-PG substrates to 3'-OH, although at the highest concentration there 
was some loss of both substrates, probably due to degradation by nucleases present in 
extracts (Figure 16). 
Processing of the single-strand PG terminated oligomer by human FLAG-Tdp1 is 
independent of cofactor requirement 
Cheng et al. in 2002 proposed that Mn2+ has a stimulatory effect on Tdp1 activity. 
Experiments carried out in our laboratory showed that adding 5mM Mn2+ in our reaction 
buffer and then looking at the processing efficiency with which the 3'-PG containing 14-
mer was processed, generated an approximately 8 % conversion of 3'-PG to 3'-phosphate 
only in the undiluted fraction (Figure 17). This is in agreement with Yang et al. (1996) 
who proposed that Tdp1 activity is independent of any co-factor requirement. According 
to them, there was no stimulation of Tdp1 activity when reactions were conducted in the 
presence of a simple buffer that was supplemented with 10mM Mg, Ca, Co, Cd and Zn. 
Tdp1 associates with XRCC1 
 The XRCC1 gene product is a scaffolding protein containing two BRCA1 
carboxyl terminal (BRCT) domains, which are binding motifs for DNA repair and cell 
cycle check points (Huyton et al., 2000). XRCC1 is implicated in single strand break 
repair pathway (SSBR) (Thompson et al., 2000) and forms a mutimeric repair complex  
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Figure 16: No evidence for the presence of other Mg+2 –dependent PG-processing 
enzymes 
 
A 3'-phosphotyrosine 18-mer or a phosphorothiaote-substituted 3'-PG 14-mer was treated 
with 1 µl of undiluted or 1 µl of seven 1:8 dilutions of JRL 1 whole-cell extract, 
containing mutant hTdp1. Each 5µl reaction was incubated at 37 ºC for 2 hours in buffer 
with 0.5 mM MgCl2 without EDTA. Samples were boiled for 1 minute at 90 ºC. A final 
concentration of 20 mM Mg2+ and 20 ng hPNKP were added. Conversion to 3'-OH was 
assessed by denaturing gel electrophoresis and quantified using ImageQuant software. 
There was no conversion to the 3'-OH substrate. 
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Figure 16 
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Figure 17: Effect of 5 mM MnP+2 Pon hTdp1 activity. 
 
A 3'-PG 14-mer was treated with 50, 6.25, 0.78, 0.098, 0.012, 0.0015, 0.0002 or 
0.000025 ng of FLAG-hTdp1, purified from adenovirus infected U-87 glioma cells. Each 
5µl reaction was incubated in buffer containing 50 mM Tris-HCl, pH 8.5/100 mM 
NaCl/5 mM MnClB2 B/1 mM DTT/ 100 µg/ml BSA at 37 ºC for 15 minutes. Conversion to 
3'-phosphate was assessed by denaturing gel electrophoresis and quantified using 
ImageQuant software. There was 8 % conversion to 3'-phosphate only in the undiluted 
fraction. 
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Figure 17 
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with several enzymes implicated in base excision and gap repair: DNA ligase III 
(Caldecott et al., 1994), PARP-1 (Caldecott et al., 1996), PARP-2 (Schreiber et al., 2002), 
DNA polymerase β (Kubota et al., 1996), PNKP (Whitehouse et al., 2001) and APE1 
(Vidal et al., 2001). Because of this scaffolding property of XRCC1, its possible 
association with Tdp1 was tested (Plo et al., 2003). Results showed that Tdp1 co-
immunoprecipitated with XRCC1 antibody and that this activity was inhibited in the 
presence of sodium vanadate, a reported inhibitor of Tdp1 (Davies et al., 2002). Western 
blot analysis also showed the presence of Tdp1 in XRCC1 immuno precipitates.  Our 
laboratory carried out a western blot analysis using anti-XRCC1 antibody to determine 
whether we could detect complexes formed by Tdp1 in cells. We used samples 
containing whole cell-extracts, a 1X TE wash obtained during the elution of Tdp1 and 
immunoprecipitated FLAG-tagged Tdp1. Our results showed the presence of XRCC1 in 
both the whole-cell extract as well as in the sample containing immunoprecipitated Tdp1 
while none was present in the wash suggesting that XRCC1 co-precipitates with Tdp1 
and a wash with 1X TE does not eliminate their binding (Figure 18a).  
XRCC1-complementation enhances Tdp1-activity 
 To determine whether XRCC1 influenced the repair of topoisomerase I covalent 
complexes, Plo and colleagues (2003), incubated a 3'-phosphotyrosine containing 14-mer 
with nuclear extracts obtained from XRCC1-deficient (EM9-V) and XRCC1-
complemented (EM9-XH) cells. Nuclear extracts from XRCC1-deficient (EM9-V) cells 
showed reduced processing of the phosphotyrosine substrate to the 14-OH product when 
compared to nuclear extracts from XRCC1-complemented (EM9-XH) cells suggesting 
that XRCC1 complementation enhances Tdp1 and PNKP activities. When we tried to  
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Figure 18a: Tdp1 associates with XRCC1 
A western (using Mouse anti-XRCC1 antibody) was carried out with samples containing 
50 ng of XRCC1 as a control, 1 µl of whole-cell extract containing FLAG-tagged hTdp1, 
10 µl of a TE wash of the whole-cell extract and 2 µl (100 ng) of 
IMMUNOPRECIPITATED FLAG-tagged hTdp1. Our results show the presence of 
XRCC1 in both the whole-cell extract as well as in the sample containing 
immunoprecipitated FLAG-tagged hTdp1 while none was present in the TE wash 
suggesting that XRCC1 co-precipitates with Tdp1 and a wash with 1X TE does not 
eliminate their binding. 
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Figure 18a 
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duplicate these results in our laboratory by incubating 3'-PG containing 14-mer with pure 
FLAG-Tdp1 (washed 3 times with salt and then purified with FLAG beads) and different 
concentrations of XRCC1, we did not see any marked increase in Tdp1 activity. Yeast 
two-hybrid experiments revealed that Tdp1 associates with the single-strand break repair 
machinery by direct interaction with DNA ligase IIIα, a partner of XRCC1 (El-Khamisy 
et al., 2005). Since, during purification, we washed our extracts in buffer containing high 
concentrations of salt, we speculated that ligase III could have been washed away, thus 
removing the bridge required for XRCC1 and Tdp1 binding. In order to check for this 
possibility, we repeated the above experiment but this time used nuclear extracts derived 
from U-87 glioma cells (FLAG-hTdp1 virus-infected cells) instead of purified Tdp1. Our 
results indeed showed that with increasing concentrations of XRCC1, Tdp1 activity is 
increased (a maximum of ~4 times) before it reaches a plateau (Figures 18b and 18c). 
 We also carried out a western blot analysis to check for the presence of Ku in 
immunoprecipitated extracts. As shown in figure 18d, although a high concentration of 
Ku was seen in the control and the whole-cell extracts, there was no indication of co-
precipitation of Ku with FLAG-hTdp1 during the latter’s immunoprecipitation, even 
though the extracts were washed only with buffer containing1X TE and no salt. 
Presence of Tdp1 protein in mitochondrial extracts 
Human mitochondria contain approximately 5-10 copies per mitochondrion of a 
covalently closed duplex DNA genome (Moraes et al., 2001). Because mitochondrial 
DNA molecules are closed circular and therefore topologically constrained, there must be 
a mechanism to relieve the DNA strain that arises during replication. Zhang et al. (2001) 
reported the existence of a mitochondrial topoisomerase I gene TOP1mt, which is  
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Figures 18b and c: Effect of XRCC1 on FLAG-hTdp1 activity  
 
A 3'-PG 14-mer (●) plus 15, 30, 45, 60 or 75 ng of recombinant XRCC1 was added to 1 
µl of undiluted nuclear extracts derived from U-87 glioma cells infected with adenovirus 
expressing FLAG-hTdp1. Samples (total volume of 5 µl) were incubated for 15 minutes 
at 37 ºC in Kedar buffer, followed by boiling of samples at 90 ºC for 1 minute. A final 
concentration of 20 mM MgClB2 Band 20 ng of PNKP were added and incubation was 
continued for 1 hour. Conversion to 3'-OH was assessed by denaturing gel 
electrophoresis and quantified using ImageQuant software. Our results showed an 
increase in hTdp1 activity (upto 4X) with increasing concentrations of XRCC1. 
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Figure 18d: A western blot analysis to check for the presence of Ku in 
immunoprecipitated hTdp1 extracts 
 
A western (using Rabbit anti-Ku 70 antibody) was carried out with samples containing 
120 ng Ku as a control, 1 µl of whole-cell extract containing FLAG-tagged hTdp1, 10 µl 
of a TE wash of the whole-cell extract and 5 µl (250 ng) of immunoprecipitated FLAG-
tagged hTdp1. Although, a high concentration of Ku was seen in the control and the 
whole-cell extracts, there was no indication of co-precipitation of Ku with FLAG-hTdp1 
during the latter’s immunoprecipitation, even though the extracts were washed only with 
buffer containing1X TE and no salt. 
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Figure 18d 
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localized on human chromosome 8q24. They found a high degree of homology between 
top1mt and nuclear topo1 which was further demonstrated by the top1mt protein being 
sensitive to CPT treatment (Tua et al., 1997), thus generating DNA strand breaks by 
blocking the re-ligation of topo1-linked DNA breaks. The formation of the mitochondrial 
topo1-DNA covalent complex lead us to speculate the presence of Tdp1 within the 
mitochondria to repair topoI-linked breaks as well as DSBs with 3′-PG termini that might 
arise as a result of oxidative stress. Western blot analysis using samples containing Tdp1 
purified from whole-cell extracts (as a control), mitochondrial extract (from GM1310 
normal human fibroblasts; gift of Penelope Mason, National Institute of Aging), whole-
cell and mitochondrial extracts from the SCAN 1 cell-lines JRL 5 (containing wild-type 
Tdp1) and JRL 3 (containing mutant Tdp1) using anti-Tdp1 antibody indeed showed 
presence of a high concentration of hTdp1 in the mitochondrial extract derived from the 
GM1310 cell-line (Figure 19). While the whole-cell extracts from both the SCAN1 cell-
lines seemed to contain hTdp1, along with some quantity of degradation products, only 
the mitochondrial extracts from JRL 5 cells showed the presence of hTdp1. 
Mitochondrial extracts show similar PG-processing efficiency as whole-cell extracts 
 We incubated serial 1:8 dilutions each of whole-cell extracts (without 
mitochondria) and mitochondrial extracts with an 18-mer containing 3'-phosphotyrosine 
for 15 minutes at 37°C and our results showed that there was no marked difference in the 
processing efficiencies between the extracts. When we carried out similar experiments 
using a 14-mer with 3'-PG, we found the same result, i.e., the difference in processing of 
the phosphotyrosine vs. PG oligomers was similar for both the whole-cell and  
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Figure 19: Western Blot analysis of whole-cell and mitochondrial extracts derived 
from GM1310 normal human fibroblasts and SCAN1 cells. 
 
A western blot was carried out using 2 µl (100 ng) of FLAG-hTdp1, purified from 
adenovirus infected U-87 glioma cells, 2 µl of mitochondrial extract derived from 
GM1310 cell-line, 10 µl of whole-cell extracts as well as 5 µl of mitochondrial extracts 
from the SCAN1 cell-lines, JRL 3 (mutant hTdp1) and 5 (wild-type hTdp1) respectively. 
The blot showed a high concentration of hTdp1 protein in the mitochondrial extract 
derived from the GM1310 cell-line. While the whole-cell extracts from both the SCAN1 
cell-lines seemed to contain hTdp1, along with some quantity of degradation products, 
only the mitochondrial extracts from JRL 5 cells showed the presence of hTdp1. 
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Figure 19 
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Figure 20: Relative end-processing efficiencies of whole-cell vs. mitochondrial 
extracts derived from GM1310 normal human fibroblasts. 
 
1 µl of undiluted or1 µl of five 1:8 dilutions of each of the whole-cell extracts and the 
mitochondrial extracts were incubated with 18-mer containing 3’-phosphotyrosine (●) or 
the 14-mer containing 3’-PG (○) for 15 minutes at 37° C in Kedar buffer containing 5 
mM EDTA. Samples were boiled for 1 minute at 90 ºC. A final concentration of 20 mM 
Mg P2+ Pand 20 ng hPNKP were added. Conversion to 3'-OH was assessed by denaturing gel 
electrophoresis and quantified using ImageQuant software. Both whole-cell extracts and 
mitochondrial extracts showed comparable phosphotyrosine and PG-processing activities.  
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mitochondrial extracts suggesting that the specificity of mitochondrial Tdp1 is very 
similar to the nuclear protein and that mitochondrial extracts contain Tdp1 at a 
concentration comparable to whole-cell extracts (Figure 20). 
Processing efficiencies of JRL 5 (wild-type Tdp1) and JRL 3 (mutant Tdp1) 
mitochondrial extracts 
Consistent with the above western blot analysis, when we compared the efficiency 
with which various 1:8 dilutions of the JRL 5 and the JRL 3 mitochondrial extracts 
process a 3'-phosphotyrosine containing 18-mer and a 3'-PG containing 14-mer, we found 
that while there was absolutely no conversion to 3'-OH with the JRL 3 mitochondrial 
extract, our results did show ~ 34% and ~ 15% conversion from 3'-phosphotyrosine to the 
3'-OH product with the undiluted and the first 1:8 diluted JRL 5 mitochondrial extracts 
respectively adding further evidence that all PG-processing activity in mitochondria is 
attributable to hTdp1. Neither the JRL-3 nor the JRL-5 mitochondrial extract showed any 
activity with the 3'-PG containing oligomer (Figure 21), consistent with the low level of 
phosphotyrosyl processing seen in the JRL-5 extract and the relative inefficiency of Tdp1 
in processing PG substrates. 
Processing of a 3'-PG oligomer is partially inhibited by Ku 
 The Ku heterodimer, consisting of a tight complex of Ku70 and Ku80, forms a 
close-fitting asymmetrical ring that threads onto the free end of DNA as a nut in a bolt 
(Walker et al., 2001). Although Ku tends to cling to DNA ends, it can translocate to the 
interior of the DNA, thus allowing multiple Ku heterodimers to load onto longer DNA 
molecules (Yaneva et al., 1997). Ku purified from human placenta by MonoQ 
chromatography also showed the presence of substantial 3'-phosphotyrosine processing  
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Figure 21: Relative end-processing efficiencies of JRL 3 and 5 mitochondrial 
extracts 
 
An 18-mer containing 3’-phosphotyrosine or a 14-mer containing 3’-PG was treated with 
1 µl of undiluted or1 µl of seven 1:8 dilutions of each of the mitochondrial extracts 
derived from JRL 3 and 5 cell-lines for 15 minutes at 37° C in Kedar buffer containing 5 
mM EDTA. Samples were boiled for 1 minute at 90 ºC. A final concentration of 20 mM 
Mg2+ and 20 ng hPNKP were added. Conversion to 3'-OH was assessed by denaturing gel 
electrophoresis and quantified using ImageQuant software. Our results showed ~ 34% 
and ~ 15% conversion from 3'-phosphotyrosine to the 3'-OH product with the undiluted 
and the first 1:8 diluted JRL 5 samples respectively and absolutely no conversion to 3'-
OH with the JRL 3 mitochondrial extract. 
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Figure 21 
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activity (Inamdar et al., 2002). This association of glycolate removing activity with 
human placental Ku raised the possibility that Ku may bind to Tdp1 and recruit it to the 
DNA ends. When we compared the efficiencies with which this purified Ku processes 
both a 3'-phosphotyrosine containing 18-mer and a 3'-PG containing 14-mer, we found 
that there was a 10-fold difference similar to that of human Tdp1 partially purified from 
lymphoblastoid while-cell extracts (figures 22a and 22b). Although Ku does not bind to 
single-stranded substrates, binding of Ku to Tdp1 could modify its specificity. To 
examine this possibility, hTdp1-catalyzed tyrosine and glycolate removal from the 18-
mer with 3'-phosphotyrosine and the14-mer with 3'-PG respectively, was assayed in the 
presence and absence of 20 ng of recombinant Ku, which unlike the human placental Ku, 
was free of any PG-processing activity. As shown in figures 23a and 23b, the effect of 
recombinant Ku was inhibitory i.e., the presence of recombinant Ku decreased the 
susceptibility of both substrates to hTdp1-mediated processing (compare to Fig 14). 
However, phosphotyrosyl processing was inhibited more than the PG-processing, so that 
in the presence of Ku the ratio of processing efficiencies was reduced from 100-fold to 
26-fold. This result suggests possible interaction between hTdp1 and Ku.  
Processing of a double-stranded substrate with 3'-PG overhang is partially inhibited 
by Ku 
 Since Ku is part of the repair complex that repairs DSBs via the NHEJ pathway, 
we looked at the effect of Ku on hTdp1 activity using a double-stranded substrate with a 
3'-PG-terminated 3' overhang. The substrate was pre-incubated with various dilutions of 
recombinant Ku for 5 minutes to allow binding to the open end of the substrate followed 
by incubation with hTdp1 for 10 minutes to allow PG-processing. Following boiling of  
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Figure 22a and b: Processing of a 3'-PG oligomer by Ku derived from placental 
tissue 
 
A 3'-phosphotyrosine 18-mer (●) or a 3'-PG 14-mer (○) was treated with 170, 21.25, 
2.65, 0.33, 0.042, 0.0052 or 0.00065 ng of Ku, purified from placental tissue by MonoQ 
chromatography. Each 5µl reaction was incubated at 37 ºC for 2 hours in Kedar buffer 
containing 5 mM EDTA. Samples were boiled for 1 minute at 90 ºC. 20 mM Mg P2+ Pand 20 
ng hPNKP were added. Conversion to 3'-OH was assessed by denaturing gel 
electrophoresis and quantified using ImageQuant software. The relative end-processing 
efficiencies was found to be approximately 10-fold. 
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Figure 22a 
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Figure 23a and b: Processing of  3'-PG and 3'-phosphotyrosine oligomers by hTdp1 
in the presence of recombinant Ku 
A 3'-phosphotyrosine 18-mer (●) or a 3'-PG 14-mer (○) was treated with 20 ng of 
recombinant Ku, commercially obtained from Trevigen, Inc., and 50, 6.25, 0.78, 0.098, 
0.012, 0.0015 or 0.0002 ng of FLAG-hTdp1, purified from adenovirus infected U-87 
glioma cells. The sample without Ku contained 50 ng of FLAG-hTdp1. Each 5µl reaction 
was incubated at 37 ºC for 15 minutes in Kedar buffer containing 5 mM EDTA. Samples 
were boiled for 1 minute at 90 ºC. 20 mM MgP2+ Pand 20 ng hPNKP were added. 
Conversion to 3'-OH was assessed by denaturing gel electrophoresis and quantified using 
ImageQuant software. The difference in end-processing efficiencies for the two 
substrates was found to be approximately 26-fold. 
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PG terminus to hTdp1 when Ku is bound to the DNA end or direct interaction between 
hTdp1 and Ku. However, there is no evidence that Ku recruits hTdp1 to DNA ends or 
facilitates hTdp1-mediated end processing (Figures 24a and 24b). 
 Since our results showed that Ku inhibited Tdp1, we carried out similar 
experiments with very high concentrations of a truncated form of Ku in order to see if 
these high concentrations inhibited the activity of Tdp1 completely. This truncated form 
lacks a carboxy-terminal 19K domain known to function in DNA-PK recruitment, but 
which is dispensable for DNA end binding (Wlaker et al., 2001) and observed that 1 µg 
concentration of truncated Ku inhibited the FLAG-hTdp1 activity by nearly 80% (Figure 
24c). 
Processing of the double-stranded substrate with 3'-PG overhang is partially 
inhibited by Ku-DNA-PK and Ku-DNA-PK-XRCC4/ligase IV complexes. 
 On comparing the processing efficiency of samples in which both Ku and DNA-
PK were incubated with the double-stranded substrate containing a 3'-PG overhang with 
that of samples in which DNA-PK was pre-incubated alone, we observed that the ability 
to process PGs by Tdp1 in samples with both Ku and DNA-PK was inhibited more than 
in samples with DNA-PK alone (Figures 25a and 25b). Similar results were observed 
when XRCC4/ligase IV was added to the complex i.e. samples containing Ku, DNA-PK 
and XRCC4/ligase IV inhibited Tdp1 activity more than samples containing DNA-PK 
and XRCC4/ligase IV only (Figures 26a and 26b). These data again suggest that once the 
end-joining repair complex is formed on DNA ends, end processing by Tdp1 is at least 
partially inhibited. 
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Figure 24a and b: Effect of different dilutions of Ku on FLAG-hTdp1 activity. 
 
A double-stranded plasmid with a 3'-PG overhang was pre-incubated with 15, 30, 45, 60 
or 75 ng (15 ng = 100fmoles) of recombinant Ku, obtained from Trevigen, Inc., for 5 
minutes in Kedar buffer followed by incubation with 0.78 ng of FLAG-hTdp1, purified 
from adenovirus infected U-87 glioma cells, for 10 minutes to allow PG-processing. 
Following boiling of the samples at 90°C for 2 minutes, the substrate was incubated with 
1000 units/ mL CIP for 1 hour at 37°C for removal of phosphate group. The samples 
were again heated at 90°C for 5 minutes and then incubated with Taq Pα P1 for 3 hours at 
65°C to yield a 15-mer with the 3'-OH. Our results showed that increasing concentrations 
of Ku had an inhibitory effect on hTdp1 activity. 
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Figure 24c: Effect of different concentrations of truncated Ku on FLAG-hTdp1 
activity 
 
A double-stranded plasmid with a 3'-PG overhang was pre-incubated with 20, 50, 100, 
200, 400 or 1000 ng of recombinant truncated Ku for 5 minutes followed by incubation 
with 0.78 ng of FLAG-hTdp1, purified from adenovirus infected U-87 glioma cells, for 
10 minutes to allow PG-processing. Following boiling of the samples at 90°C for 2 
minutes, the substrate was incubated with CIP for 1 hour at 37°C for removal of 
phosphate group. The samples were again heated at 90°C for 5 minutes and then 
incubated with TaqPα P1 for 3 hours at 65°C to yield a 15-mer with the 3'-OH. Our results 
showed that increasing concentrations of Ku had an inhibitory effect on hTdp1 activity. 
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Effect of different dilutions of Ku-DNA-PK complex on FLAG-hTdp1 activity 
 
Figure 25a- A double-stranded plasmid with a 3'-PG overhang (2 fmoles) was pre-
incubated with 27 ng of recombinant Ku (180 fmoles) and 0, 4, 20, 100, 200 or 300 ng of 
DNA-PK for 5 minutes at 25 °C followed by incubation with 0.78 ng of FLAG-hTdp1, 
purified from adenovirus infected U-87 glioma cells, for 10 minutes in Ramsden buffer 
containing 100 µM ATP and 5 mM MgClB2B to allow PG-processing. After boiling of the 
samples at 90°C for 2 minutes, the substrate was incubated with CIP for 1 hour at 37°C 
for removal of phosphate group. The samples were again heated at 90 °C for 5 minutes 
and then incubated with Taq Pα P1 for 3 hours at 65°C to yield a 15-mer with the 3'-OH. Our 
results showed that samples containing Ku and DNA-PK inhibited Tdp1 activity more 
than samples containing DNA-PK only. 
Figure 25b: The experiment was carried out in triplicates; each showing a similar result. 
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Figure 25b 
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Effect of different dilutions of Ku-DNA-PK-XRCC4/ligase IV complex on FLAG-
hTdp1 activity 
 
Figure 26a: A double-stranded plasmid with a 3'-PG overhang was pre-incubated with 
27 ng of recombinant Ku (180 fmoles) and 0, 4, 20, 100, 200 or 300 ng of DNA-PK for 5 
minutes at 25 °C followed by pre-incubation with 10 nM XRCC4/ligase IV (50 fmoles) 
for 5 minutes at 25 °C. reactions were carried out in Ramsden buffer containing 100 µM 
ATP and 5 mM MgCl B2 B. A control experiment in which the double-stranded plasmid was 
incubated with DNA-PK and XRCC4/ligase IV was also simultaneously carried out. 0.78 
ng of FLAG-hTdp1, purified from adenovirus infected U-87 glioma cells, was added for 
10 minutes to allow PG-processing. Following boiling of the samples at 90°C for 2 
minutes, the substrate was incubated with CIP for 1 hour at 37°C for removal of 
phosphate group. The samples were again heated at 90 °C for 5 minutes and then 
incubated with TaqPα P1 for 3 hours at 65°C to yield a 15-mer with the 3'-OH. Our results 
showed that samples containing Ku, DNA-PK and XRCC4/ligase IV inhibited Tdp1 
activity more than samples containing DNA-PK and XRCC4/ligase IV only. 
Figure 26b: the experiment was carried out in triplicates; each showing similar results. 
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Figure 26a 
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Figure 26b 
 
 
ng of DNA-PK
0 50 100 150 200 250 300
%
 c
on
ve
rs
io
n
0
20
40
60
80
100
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ng of DNA-PK
0 50 100 150 200 250 300
%
 c
on
ve
rs
io
n
0
20
40
60
80
100
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ng of DNA-PK
0 50 100 150 200 250 300
%
 c
on
ve
rs
io
n
0
20
40
60
80
100
 
 
XRCC1+DNA-PK + Ku 
 
DNA-PK + XRCC1 
 
 
 
  124   
Inhibition of DNA-PK autophosphorylation does not show a marked inhibition on 
Tdp1 activity. 
Chan et al. (2002) and Soubeyrand et al. (2003) indicated that cellular end-joining 
requires DNA-PKcs to undergo autophosphorylation. They showed the presence of six 
autophosphorylation sites clustered within a 40-amino acid region. Later, Reddy et al. 
(2004) showed that autophosphorylation at these six sites uniquely makes DNA ends 
accessible while still allowing DNA-PKcs to persist at ends and retain XRCC4-ligase IV 
within a complex at the ends. Their results indicate that autophosphorylation of the six 
sites leads to a destabilization of DNA-PK that is critical for significant end-joining 
activity. Therefore, they propose that autophosphorylation within the six sites is uniquely 
able to direct a rearrangement of the DNA-PK complex at DNA ends that is essential for 
end-joining both in vitro as well as in cells. Based on this information, we looked at the 
effect of autophosphorylation of DNA-PK on Tdp1 activity. We assumed that since, 
according to Reddy and colleagues, autophosphorylation destabilizes DNA-PK and 
increases cellular end-joining, inhibition of autophosphorylation would stabilize the 
DNA-PK on the DNA ends, thus markedly inhibiting the Tdp1 activity. But our results 
showed that the presence of ATP (Figures 25a and b) resulted in only a slight reduction in 
the inhibition caused by presence of DNA-PK at the DNA ends. Thus based on results 
with purified proteins, autophosphorylation of DNA-PK does not appear to play a major 
role in regulating accessibility of DNA ends to hTdp1 (Figures 27a and 27b). it is 
possible that the putative conformational change in DNA-PK that is induced by 
autophosphorylation has a greater effect on the susceptibility of DNA ends to 
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exonucleolytic degradation (which was assayed by Reddy et al) than to simple glycolate 
removal by Tdp1. 
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Effect of inhibition of autophosphorylation of DNA-PK on hTdp1 activity. 
 
Figure 27a: A double-stranded plasmid with a 3'-PG overhang (2 fmoles) was pre-
incubated with 27 ng of recombinant Ku (180 fmoles) and 0, 4, 20, 100, 200 or 300 ng of 
DNA-PK for 5 minutes at 25 °C followed by incubation with 0.78 ng of FLAG-hTdp1, 
purified from adenovirus infected U-87 glioma cells, for 10 minutes in Ramsden buffer 
without ATP and Mg P+2 P. A control experiment in which the double-stranded plasmid was 
incubated with DNA-PK and FLAG-hTdp1 alone was also simultaneously carried out. 
After boiling of the samples at 90°C for 2 minutes, the substrate was incubated with CIP 
for 1 hour at 37°C for removal of phosphate group. The samples were again heated at 90 
°C for 5 minutes and then incubated with Taq Pα P1 for 3 hours at 65°C to yield a 15-mer 
with the 3'-OH. Our results showed did not show a dramatic inhibition of hTdp1 activity 
as was expected. 
Figure 27b: The experiment was carried out in triplicates; each showing a similar result. 
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Figure 27b 
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                                                            Discussion 
 
 
 
The main conclusions of this study are- 1. Altered specificity of Tdp1 in extracts vs. 
recombinant Tdp1 is due to interactions with other proteins rather than post-translational 
modification. 2. There was no detectable binding of NHEJ proteins with Tdp1 by western 
blot analysis. 3. All NHEJ proteins alone or in combination inhibited Tdp1 activity on 3‘-
overhangs. 4. Mitochondria contain PG and phosphotyrosine processing activity 
attributable to Tdp1. 
DSBs induced by radiomimetic antibiotics such as neocarzinostatin and 
calicheamicin typically have PG-terminated 3′ overhangs at one end of the break (Giloni 
et al., 1981). About half of radiation-induced strand breaks also have 3′-PG termini 
(Henner et al., 1983), and many of these are presumably on 3′ overhangs of DSBs. In the 
repair of such lesions, removal of the 3′-PG termini must necessarily precede any 
polymerase-mediated gap filling and/or religation of the DSB. However, while the human 
apurinic/apyrimidinic endonuclease Ape1 can remove PGs, albeit inefficiently, from 
blunt and recessed 3′ termini of DSBs, PGs on 3′ overhangs are completely refractory 
(Suh et al., 1997). The human polynucleotide kinase/phosphatase PNKP, which removes 
3′ phosphates from single-stranded 3′ termini (Jilani et al., 1999), also had no detectable 
effect on 3′-PGs (Inamdar et al., 2002), just as was previously reported for rat 
polynucleotide kinase/phosphatase (Habraken et al., 1988). The susceptibility of 3′-PGs 
to E.coli exonuclease I (Sandigursky et al., 1993) raised the possibility that PGs on 3′ 
overhangs might be removed by a mammalian 3′-> 5′ exonuclease. However, DNase III, 
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which is the dominant 3′->5′ exonuclease in mammalian cell extracts, has no detectable 
effect on any 3′-PG substrates (Inamdar et al., 2002). The Wrn1 and Mre11 3′->5′ 
exonucleases are also unlikely candidates because both show a strong preference to 
recessed 3′ termini and 3′ overhangs, even if unblocked, are resistant to these enzymes 
(Kamath-Leob et al., 1998, Huang et al., 2002). The Sacchromyces cerevisiae 
Rad1/Rad10 endonuclease (and presumably its human ERCC1/XPF homolog) can 
remove a single 3′-PG (or 3′-OH) nucleotide from the 3′ end of a single-strand break in 
double-stranded DNA (Guzder et al., 2004), but no such activity has been reported on 
PG-terminated 3′ overhangs. Similarly, while Artemis, a DNA-PK activated 
endo/exonuclease, has been implicated in DSB repair (Moshous et al., 2001), this enzyme 
appears to act only on 3′-overhangs longer than 4 bases (Ma et al., 2002). Nevertheless, 
PGs on overhanging 3′ termini clearly are processed in Xenopus, human and hamster cell 
extracts (Ma et al., 2002). 
 Evidence for a 3′-phosphate intermediate in 3′-PG removal in human cell extracts 
(Inamdar et al., 2002) suggested possible involvement of hTdp1, and indeed, experiments 
carried out in our laboratory showed that both hTdp1 and scTdp1 were found to catalyze 
similar glycolate removal from a single-stranded oligomer as well as from a single-strand 
overhang of a DSB. Failure to detect this activity in previous studies could have been due 
to the very small difference in electrophoretic mobility between 3′-PG and 3′-phosphate 
oligomers and the relative inefficiency of PG processing by recombinant hTdp1 
compared to its normal substrate, 3′-phosphotyrosine.  
 DSBs generated by ionizing radiation cannot be repaired by simple ligation 
because end joining is more complex due to the presence of fragmented sugars and 
  131   
damaged or missing nucleotides at DNA ends. DNA treated with antibiotic bleomycin 
(Giloni et al., 1981) or exposed to IR (Henner et al., 1983) contains DSBs formed by 
sugar oxidation and fragmentation. Free radical-mediated oxidation of the C-4′ position 
of the deoxyribose in DNA results in sugar fragmentation and strand cleavage, releasing 
base propenal and leaving the two-carbon fragment-POB4BCHB2 BCOOH, or PG, linked to the 
3′-end of the break. These end groups will block the activities of DNA polymerase and 
DNA ligase enzymes (Noguti et al., 1975). About half of radiation-induced strand breaks 
have 3′-PG termini and many of these are presumably on 3′-overhangs of DSBs. In the 
repair of such lesions, removal of the 3′-PG termini must necessarily precede any 
polymerase-mediated gap filling and/or religation of the DSB. Strand breaks with 
modified 3-termini are two times more toxic than their 3′-OH counterparts (Kow et al., 
1991).  
 Tyrosyl DNA phosphodiesterase (Tdp1) is the only enzyme known so far to 
function in DNA repair and remove blocks to leave 3′--phosphate ends. Our results 
showed that both yeast and human Tdp1 processed PG substrates efficiently and gave rise 
to 3′-phosphate product corresponding to a band that migrated between the PG and 
hydroxyl bands. Thus, Tdp1 is capable of selectively removing the glycolate from PG to 
leave behind 3′-phosphate ends that are efficiently converted to hydroxyl ends by PNKP 
as indicated by generation of a 3′-OH when the substrate was incubated with both the 
enzymes together. The crystal structure of hTdp1 (Davies et al., 2002) shows the 
presence of an active site in the enzyme consisting of histidine and lysine residues that 
are conserved in the HKD motif of phospholipase D superfamily of proteins, of which 
Tdp1 is a member. These residues lie close to a 40A long cleft that runs along one surface 
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of the protein. The active site is in the center of a 2-fold axis of symmetry between two 
domains in the enzyme. Based on structural and biochemical data, the conserved PLD 
superfamily reaction mechanism has been proposed to consist of two consecutive SN2 
substitutions (Interthal et al., 2005). In the first step of the reaction, a histidine residue in 
the N-terminal HKD motif (His263) is proposed to carry out a nucleophilic attack on the 
phosphorous atom in the phosphodiester bond between the tyrosine residue and the DNA 
3′ oxygen to become covalently attached to the 3′ end of the DNA via a phosphoamide 
bond to the Nε2 atom of the nucleophilic His263 (Davies et al., 2003 and Raymond et al., 
2004). In the final step, hydrolysis of this intermediate is believed to be carried out by a 
water molecule that is activated by His493 from the C-terminal HKD motif acting as a 
general base. This Tdp1 catalysis thus produces free tyrosine and a DNA with a 3′-
phosphate end. Thus, it is tempting to speculate here that a histidine residue from one 
domain of the active site could carry out a nucleophilic attack on the phosphorous from 
the PG group thus leading to the dissociation of glycolate to leave behind 3′-phosphates. 
The PG substrate however, required a higher concentration of the enzyme (scTdp1 as 
well as hTdp1) than the control phosphotyrosine substrate. The crystal structure of the 
enzyme as well as its mode of action on the topoisomerase I-DNA complexes may help 
to explain this difference in substrate specificity. The topoisomerase I-DNA 
phosphodiester bond is buried deep inside the covalent complex (Davies et al., 2002) and 
topoisomerase I needs to be degraded and the DNA unwound for easy access and 
efficient functioning of the enzyme. Therefore, DNA unwinding as well as the presence 
of a protein at the end of the DNA, both may be necessary pre-requisites for optimal 
functioning of the enzyme. The PG substrate lacks this protein-DNA configuration at its 
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end. This difference in end-structure of the substrate may account for the lower efficiency 
of Tdp1 on PG substrates. Since our experiments provided no evidence that the low 
activity of the recombinant enzyme on the PG substrates when compared to crude or 
fractionated cell extracts was due to lack of proper post-translational modifications, 
presence of the N-terminal epitope tag, or degradation or alteration of the recombinant 
protein during its preparation, we can speculate that the apparent increase in the inactivity 
of the native protein toward PG substrates may be the effect of its interactions with other 
repair factors in the extracts. 
 Although Cheng et al. in 2002 proposed that Mn2+ has a stimulatory effect on 
Tdp1 activity, our experiments showed that adding 5mM Mn2+ in our reaction buffer did 
not show any increase in PG-processing activity of hTdp1. This is in agreement with 
Yang et al. (1996) who proposed that Tdp1 activity is independent of any co-factor 
requirement. According to them, there was no stimulation of Tdp1 activity when 
reactions were conducted in the presence of a simple buffer that was supplemented with 
10mM Mg, Ca, Co, Cd and Zn. Experiments conducted in our laboratory also showed 
that both crude extracts as well as purified Tdp1 (both yeast and human) processed PGs 
in the presence of EDTA suggesting that glycolate removal was independent of co-factor 
requirement.  
Human mitochondria contain ~5-10 copies per mitochondrion of a covalently 
closed duplex DNA genome (Moraes et al., 2001). Because mitochondrial DNA 
molecules are closed circular and therefore topologically constrained, there must be a 
mechanism to relieve the DNA strain that arises during replication. Zhang et al. (2001) 
reported the existence of a mitochondrial topoisomerase I gene TOP1mt, which is 
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localized on human chromosome 8q24. They found a high degree of homology between 
top1mt and nuclear topo1 which was further demonstrated by the top1mt protein being 
sensitive to CPT treatment (Tua et al., 1997), thus generating DNA strand breaks by 
blocking the re-ligation of topo1-linked DNA breaks. The formation of the mitochondrial 
topo1-DNA covalent complex lead us to speculate that Tdp1 within the mitochondria 
may be involved in repair of DSBs with 3′-PG termini that might arise as a result of 
oxidative stress. Indeed our western blot analysis of mitochondrial extracts from the GM 
cell line showed the presence of Tdp1. Our substrate processing assays also show that 
both the whole-cell and mitochondrial extracts have comparable PG and tyrosine 
processing efficiencies suggesting that mitochondrial Tdp1 is as abundant as its 
cytoplasmic counterpart. 
 DNA DSB repair in vertebrate cells occurs mainly by the mechanism of non-
homologous end-joining. This phenomenon was first demonstrated in CV1 monkey 
kidney cells by transfecting into them a plasmid with a polylinker inserted in the intron of 
SV 40 T-antigen. Prior to transfection, the polylinker was restriction digested with 
various enzymes to create linear DNA with mismatched ends (Roth and Wilson, 1986). 
Analysis of repair joints formed by the system from linearized plasmids revealed that 
ends with non-complementary or partially complementary 3′ and 5′-overhangs were in 
many cases efficiently joined via post-repair ligation without loss of any nucleotides at 
their termini. This ligation involved alignment of short partial complementarities from 
each single-stranded extensions to create gaps in both single strands to be filled in by a 
polymerase to create ligatable nicks. Similar experiments using Xenopus extracts 
(Pfeiffer et al., 1994) supported this post-repair ligation process whereby protruding 
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DNA ends are held in alignment during processing of mismatched 3-overhangs followed 
by fill-in synthesis. These experiments suggested the existence of alignment factor(s) to 
properly align the protruding single-strand tails in short overlaps as well as to hold 
abutting ends in juxtaposition. Petra Pfeiffer et al. provided a direct evidence for 
existence of such an alignment factor by showing that the efficiency and accuracy of 
NHEJ is dramatically reduced in xrs6 extracts deficient in Ku 70/80 heterodimer and that 
the lack of accuracy was due to inability to align the two broken ends for DNA fill-in 
synthesis (Feldmann et al., 2000). These results imply that Ku plays a critical role in 
aligning the two broken ends together and protecting the overhangs during end-joining. 
Further proof came from experiments that showed that Ku actively binds the ends of 
DNA DSBs and promotes association of the DNA ends with each other (Pang et al., 
1997). One heterodimer binds to each end and the two heterodimers interact with each 
other (Cary et al., 1997), thereby bridging the two DNA ends. This serves to protect the 
ends from processing and degradation as well as accounts for stimulation of 
intermolecular ligation by eukaryotic ligases (Ramsden and Gellert, 1998). DNA-PKcs 
associates with the Ku heterodimer and is recruited to the DNA ends by Ku which then 
activates its kinase function Featherstone and Jackson, 1999). A number of proteins can 
be phosphorylated by DNA-PK but the significance of this phosphorylation is not clear. 
Several observations, including its ability to associate with and phosphorylate Artemis 
thus, activating the latter’s endonuclease activity (Ma et al., 2002), suggest a specific role 
for DNA-PKcs in directing end-processing events; however, DNA-PKcs deficiency 
affects cellular end-joining even when processing is not required (Bogue et al., 1998). A 
more general role for DNA-PKcs in end-joining is also consistent with in vitro evidence 
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indicating that it helps Ku recruit the XRCC4-ligase IV complex to DNA ends (Chen et 
al., 2000) and promotes the intermolecular synapsis of two the DNA ends (DeFazio et al., 
2002). Together, these functions of DNA-PKcs may explain why XRCC4-ligase IV 
activity is necessary in vitro when using substrates that do not require processing 
(Hanakahi et al., 2000). 
 Valerie and Povirk (2003) proposed an in vitro model for the NHEJ repair 
pathway. According to their proposal, DNA DSBs induced by IR or bleomycin with 3′-
PGs are first recognized by Ku heterodimer. Upon binding to the ends, Ku properly 
positions itself such that it bridges the two ends and aligns them together for repair to 
proceed by fill-in and ligation. Ku then recognizes the PG groups at the ends and recruits 
hTdp1 and PNKP, which then effectively carry out the conversion of PG to glycolate to 
hydroxyl ends in sequential and well-coordinated steps. The hydroxyl ends are bound and 
protected by Ku until it recruits DNA-PKcs, which displaces Ku ~10 base pairs to the 
interior of the DNA from the ends so that its can properly align itself at the end. DNA-PK 
then recruits and phosphorylates additional proteins such as exonucleases, Artemis and 
XRCC4/DNA ligase IV to the ends to form the NHEJ repair complex. DNA-PK finally 
undergoes autophosphorylation and removes itself from the ends to allow fill-in and re-
ligation. But experiments conducted in our laboratory did not show any evidence for the 
above model. In our experiments, when purified Ku alone was pre-incubated with 
substrates followed by addition of Tdp1, Ku had an inhibitory effect on the removal of 
glycolate by Tdp1. If Ku did recruit Tdp1, then there should have been an increase in the 
latter’s activity, not a marked inhibition. Ku is known to bind to the broken DNA ends 
and protect them from degradation by nucleases. The inhibitory effect of Ku on Tdp1 is 
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in agreement with this well acknowledged function of Ku. It is possible that Tdp1 
actually processes the DNA ends even before Ku binds to it. It is also possible that in the 
presence of Ku, DNA cannot be properly threaded into the DNA binding cleft on Tdp1 
protein. Cross-linking studies (Yoo and Dynan, 2000) show that when DNA-PK is 
recruited to the ends, Ku moves to the interior of the DNA, facilitating the binding of 
DNA-PK. Our Tdp1 activity assays comparing the processing of a plasmid substrate 
containing 3′-PG overhang by samples in which Ku-DNA-PK complex was pre-
incubated versus samples in which DNA-PK was pre-incubated alone showed that when 
both Ku and DNA-PK are present together, there is more inhibition of Tdp1 activity than 
with DNA-PK alone. Therefore, though theoretically there was a possibility that once Ku 
moves interior, the positioning of DNA-PK on the DNA molecule may actually facilitate 
the access of Tdp1 to the PG groups, our results showed otherwise. One would also 
predict that autophosphorylation of DNA-PK, which is required for its removal from the 
DNA-ends, would facilitate Tdp1 activity but once again, our results from experiments 
conducted without addition of ATP, did not show a marked inhibition of Tdp1 activity 
which should have been brought about if the ends were blocked by DNA-PK. The pre-
incubation of three of the NHEJ key proteins-Ku, DNA-PK and XRCC4-ligase IV also 
produced a high inhibition of Tdp1 activity. Because of this suppression of Tdp1 activity 
by DNA-PK, it is tempting to speculate here that such a suppression may require the 
synapsis of two DNA/DNA-PK complexes (Hammarsten et al., 2000). In intact cells, the 
bringing together of two broken DNA ends could be quite a slow and complex process 
(DiBiase et al., 2000), and thus the ability or inability of DNA-PK to protect lone DNA 
ends from processing could strongly affect the ultimate nature and fidelity of repair. 
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 Takashima et al. (2002) observed that mutation of Tdp1 is associated with 
spinocerebellar ataxia with axonal neuropathy (SCAN1). The association of this DNA 
repair protein with SCAN1 is striking in that this is a disease characterized by 
neurodegeneration but which lacks any obvious extra neurological features such as 
genetic instability or cancer. Although not proven, it is generally assumed that SCAN1 
pathology is a consequence of the failure of mutant Tdp1 to efficiently repair topo1-
associated DNA damage (Takashima et al., 2002). This repair deficiency could indirectly 
confer sensitivity to oxidative damage, as certain oxidative lesions tend to promote 
formation of topo1 cleavable complexes (Pourquier et al., 1999), which upon replication 
can be converted to cytotoxic topo1-terminated DSBs (Hsiang et al., 1989). Previous 
experiments in our laboratory showed that in extracts of SCAN1 cells harboring mutant 
Tdp1, there was no detectable processing of a PG terminus on a three-base 3′-overhang 
formed by free radical-mediated DNA cleavage (Zhou et al., 2005). Because a substantial 
proportion of DNA breaks induced by ionizing radiation bear 3′-PG termini (Henner et 
al., 1983), cells deficient in processing of PG-terminated DSBs were expected to be 
profoundly radiosensitive. However, Zhou et al. (2005) showed that, in cell growth 
assays, only slight radiosensitivity was detected in two of three SCAN 1 cell lines, and 
then only for fractionated radiation in plateau phase. These results suggest that most PG-
terminated DSBs are still repaired in SCAN1 cells, presumably by Tdp1-independent 
pathways. Blunt and recessed 3′-PG ends could be processed by Ape1, while 3′-
overhangs longer than four bases could be processed by Artemis. Thus, the fraction of 
radiation-induced DSBs that strictly require only Tdp1 for repair may be very small, 
possibly less than 10%. Even for these breaks, there may be an alternative, more 
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complicated pathway that can substitute when simpler end-joining pathways fail, as 
suggested by the ‘repair foci’ of DSB repair factors that can be detected cytologically 
long after majority of DSBs have already been repaired (Bradbury et al., 2003). Whether 
protruding PG termini on DSBs are more persistent in SCAN1 than in normal cells in 
vivo is not known, and although a post-labeling assay for PG-formation and repair in vivo 
has been described previously (Weinfeld et al., 1991 and Bertoncini et al., 1995), this 
assay is relatively insensitive and does not distinguish between SSB and DSB termini. To 
investigate the molecular basis of SCAN1, El-Khamisy et al. (2005) carried out both 
quantitative γ-H2AX immunostaining and neutral comet assays. When both of these 
experiments failed to reveal a measurable difference between the level of DSBs in non-
replicating normal and SCAN1 cells, they suggested that more than 98% of the breaks 
that occur accumulate in non-replicating SCAN1 cells are SSBs (El-Khamisy et al., 
2005). Topoisomerase I transiently generates SSBs as a part of its normal catalytic cycle, 
during which it becomes covalently attached to the 3′- terminus of the break until the 
SSB is subsequently resealed by the topoisomerase (Wang et al., 2002). With regard to 
the source of SSBs in SCAN1 cells, replication-independent topo1-associated SSBs can 
arise by collision of cleavage complexes with RNA polymerases or by close proximity 
with other DNA adducts (Pommier et al., 2003). While a loss of Tdp1 function in DSB 
repair results in little or no observable phenotype in replicating tissues, how does loss of 
Tdp1 cause a dramatic phenotype in non-replicating neurons? To address this question, 
El-Khamisy et al. (2005) mimicked the postmitotic state of neurons by arresting mitosis 
in lymphoblastoid cells from SCAN1 patients and then exposed the cells to the Topo1 
poison, camptothecin. Campothecin treatment caused abundant SSBs in the DNA. When 
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camptothecin was removed, SCAN1 cells did not repair the breaks whereas wild-type 
cells did so rapidly. Importantly, SSBs induced by oxidative stress, another DNA 
damaging agent, also were inefficiently repaired in SCAN1 cells. Additional yeast two-
hybrid, co-immunoprecipitation, and reconstitution studies showed that normal human 
cells possess a novel Tdp1-dependent SSBR process (consisting of Tdp1, XRCC1, PNKP 
and Ligase IIIα) that rapidly repairs topo1-SSBs, and that this process is absent in 
SCAN1 cells. Consistent with this information, western blot analysis carried out by our 
laboratory indeed showed the presence of XRCC1 in purified Tdp1 extract (washed once 
with 1X TE prior to elution), adding further proof to statements made by El-Khamisy and 
colleagues. Our processing assays with nuclear extracts obtained from adenovirus-
infected U87 cells showed that XRCC1 was found to enhance Tdp1 activity up to 4X. 
Keeping this information in mind, it would be interesting to check if mutated Tdp1 binds 
to XRCC1 at all; if there is no evidence of binding then it would be tempting to speculate 
that the binding site for XRCC1 is contained within the mutation.  
Yet another role for Tdp1 in SCAN1 was presented by Interthal et al. (2005) who 
stated that, in combination with 3′-PG as a substrate, Tdp1 may also function to remove a 
variety of 3′ adducts including those that contain a 3′-biotin or a 3′-abasic site. Using a 
tryptic peptide of Tdp1 H493R (mutant form of Tdp1 in SCAN1) bound to the 3′-end of 
an oligonucleotide as a substrate for wild-type Tdp1, their data showed that Tdp1 is 
capable of hydrolyzing the phosphamide linkage between the peptide and the DNA. They 
observed that unlike the native topo1-DNA complex, which is not a substrate for Tdp1, 
Tdp1 removed a fully folded Tdp1 enzyme from the DNA. They speculated that Tdp1 
somehow promotes sufficient unfolding of the Tdp1-DNA complex for its active site to 
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access the phosphoamide bond to be cleaved. Patients who are affected by the SCAN1 
disease develop neurodegenerative symptoms during their teenage years (Takashima et 
al., 2002). The disease is completely recessive and heterozygous individuals remain 
symptom free. Based on the data provided by Interthal and colleagues, we can conclude 
that any H493R covalent complexes that accumulate in heterozygous individuals are 
repaired by wild-type Tdp1 and this likely accounts for the recessive nature of the 
SCAN1 defect. 
 But why might the pathology of SCAN1 be restricted to neurons? One possibility 
is that elevated oxidative stress in post-mitotic neurons creates a particularly high level of 
SSBs. In addition, the limited regenerative capacity of the nervous system might render 
this tissue particularly susceptible to cell loss, where as cell loss from tissues with greater 
regenerative capacity might be better tolerated. Another possibility might be that 
unrepaired SSBs can be processed by homologous recombination in proliferating cells, 
even in the absence of DNA replication, as in budding yeast. Consistent with this idea 
was observation by El-Khamisy et al. (2005) that HR-defective XRCC3-/- chicken DT40 
cells accumulated high levels of replication-dependent strand breaks during treatement 
with CPT, confirming that HR repairs replication-associated DSBs in higher eukaryotes. 
They also observed that there was an increased frequency of spontaneous sister chromatid 
exchanges and an additional increase in these events in SCAN1 cells after exposure to 
CPT concentrations too low to trigger the exchanges in normal cells, suggesting that HR 
is indeed elevated in SCAN1 cells. Finally, it is possible that Tdp1 has additional, unique 
functions in neurons distinct from its DNA repair activities. It is also interesting to note 
that, based on clinical features, brain imaging and limited neuropathological studies, the 
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most susceptible neurons in ataxia with oculomotor apraxia (AOA1), AOA type 2, and 
presumably SCAN1 seem to include large, highly metabolic neurons, such as cerebellar 
Purkinje cells, motor neurons, and dorsal root ganglia. AOA1 cells are sensitive to 
hydrogen peroxide and harbor a mutation in aprataxin; a protein that interacts with 
XRCC1 (Mossesso et al., 2005). AOA2 is caused by mutations in senataxin; a protein 
that likely functions in RNA processing and transcription-coupled DNA repair (Ursic et 
al., 2004). RNA interference (RNAi) technology can also be harnessed to reduce Tdp1 
levels in cultured neurons and in vivo. Viral-mediated RNAi knockdown in the 
cerebellum versus other brain regions could address regional susceptibility. If Tdp1-
deficient neurons are shown to accumulate SSBs, it will be critically important to 
determine whether this genotoxic stress induces a DNA damage response or alters the 
neuronal transcriptome, as one might predict with these results. Another important line of 
inquiry will be to determine whether the AOA1 disease protein aprataxin, ties into Tdp1-
dependent processes due to its link with SSBR. While the connection of the AOA2 
disease protein senataxin is less well established, its predicted involvement both in RNA 
processing and in transcription-coupled repair further suggests intriguing links between 
DNA repair and transcription in neurodegeneration.  
Nevertheless, a role for PG-terminated DSBs in SCAN1 pathology cannot be 
excluded. In cycling wild type yeast and mammalian cells, cell death induced by abortive 
topo1 strand breaks appears to result largely, if not entirely, from DSBs arising at 
replication forks (Vance et al, 2002 and Pouliot et al, 2001). In addition, mutation of 
genes required for homologous recombination, a process that is essential for repairing 
DSBs at collapsed replication forks, confers high levels of sensitivity to camptothecin in 
  143   
both yeast (Vance et al., 2002) and mammalian cells (Caldecott et al., 1991). Consistent 
with these observations, in budding yeast Tdp1 appears to operate in concert with 
homologous recombination specifically at topo1-DSBs associated with replication. The 
neuronal apoptosis seen in knockout mice lacking critical DNA end-joining proteins, 
such as XRCC4 and DNA ligase IV (Gao et al., 1998 and Barnes et al., 1998), suggest 
that in the absence of DSB repair terminally differentiating neurons accumulate sufficient 
DSBs to produce significant neurological pathology. There is evidence that at least some 
of these ‘spontaneous’ DSBs reflect damage by oxygen free radicals associated with 
normal oxidative metabolism (Karanjawala et al., 2003). For Friedreich ataxia (FA) and 
other ataxias in which oxidative stress is considered to be an important pathogenic 
element, damage to DNA (including but not limited to SSBs) and subsequent 
transcriptional alterations could prove to be an important downstream consequence of 
oxidative stress. FA is associated with a mutant frataxin protein, which leads to increased 
oxidative stress due to a defect in iron homeostasis (Lodi et al., 2002 and Schulz et al., 
2003). Remarkably, FA shares some of the same neuropathological hallmarks with 
SCAN1, including degenration of posterior columns and dorsal root ganglia. Thus, while 
most recent papers imply a role of SSBR in SCAN1 cells, several lines of circumstantial 
evidence also suggest a possible linkage among Tdp1 deficiency, oxidative damage, 
DSBs and cerebellar ataxia. Even though lymphoblastoid cell lines derived from SCAN1 
patients show at most only mild radiosensitivity (Zhou et al., 2005), it is possible that 
endogenous tissues of SCAN1 patients are more sensitive to free radical damage than the 
cell lines. Because cultured cells are subjected to higher oxygen tensions than would 
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occur in vivo, they may be more likely to adapt to Tdp1 deficiency, for example, by 
upregulating alternative pathways for repair of DSBs and other oxidative damage. 
Clinical significance 
 
 Elucidating the mechanism of NHEJ is integral to understanding how normal cells 
can avoid oncogenic transformation when challenged with the DNA DSB lesions, but 
also for exploiting this pathway for cancer therapeutics. With the advent of gene therapy, 
it may be possible to prevent carcinogenesis and hypersensitivity to radiation in patients 
who have been diagnosed with any of the NHEJ gene deficiency. It is a well-known fact 
that many tumors that are amenable to treatment by either chemotherapy or radiotherapy 
become resistant to treatment after a period of time. Recurrence of the tumor after going 
into remission is also a major challenge faced today in the treatment protocols of 
certaincancers. Majority of the drugs or other modalities of treatment concentrate on 
causing DNA damage to an extent that renders cells incapable of survival. However, very 
few drugs target proteins involved in the repair of these DNA breaks. NHEJ is now a 
well-established mode of DSB repair in vertebrate cells that involves Ku, DNA-PK and 
XRCC4/DNA ligase IV as the key players in addition to others like Artemis and DNA 
polymerase. Also, a role for Tdp1 in NHEJ repair cannot be completely excluded at this 
point. What is the contribution of the NHEJ process and the proteins involved in this 
process in the development of resistance by a tumor or recurrence of a tumor? It is 
possible that a cancerous cell has elevated levels of these repair factors that enable the 
cell to survive in spite of treatment and also contribute to recurrence. A robust repair 
system can attenuate response to treatment. Knowing what proteins play a crucial role in 
such repair systems and their structure and function will aid in the development of 
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specific and potent inhibitors of these proteins. For example, LY294002, IC87361 and 
wortmanin are well known inhibitors of DNA-PK and completely abolish end-joining. 
Sodium ortho-vanadate is the only known inhibitor of Tdp1 (Davies et al., 2002). Such 
specific inhibitors can be combined with conventional chemotherapeutic agents to 
enhance the latter’s effectiveness as cytotoxic agents. This can be of an added advantage 
in that it can also help in reducing the toxic effects associated with high doses of 
chemotherapy. While inhibition of Tdp1 may not confer radiosensitivity, it would likely 
confer sensitivity to topoI-mediated agents such as camptothecin. However, it will be first 
necessary to develop inhibitors that are more specific to these proteins, before the 
feasibility of this approach can be tested. 
 Molecular diagnostics is a rapidly advancing field in which insights into disease 
mechanisms are being elucidated by use of new gene-based biomarkers. Until recently, 
diagnostic and prognostic assessment of diseased tissues and tumors relied heavily on 
indirect indicators that permitted only general classifications into broad histologic or 
morphologic subtypes and did not take into account the alterations in individual gene 
expression. Global expression analysis using microarrays now allows for simultaneous 
interrogation of the expression of thousands of genes in a high-throughput fashion and 
offers unprecedented opportunities to obtain molecular signatures of the state of activity 
of diseased cells and patient samples. Microarray analysis may provide invaluable 
information on disease pathology, progression, resistance to treatment, and response to 
cellular microenvironments and ultimately may lead to improved early diagnosis and 
innovative therapeutic approaches for cancer.  Development of new molecular markers as 
diagnostic probes has revolutionzed the detection methods for certain cancers in their 
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very early stages. For example, p63, a homologue of the tumor suppressor gene p53, is 
now known to be a useful marker for clinically undetectable but ultrasound suspected 
prostate cancers. The discovery of SCAN1 gives rise to the important question as to what 
cancers, if any, may have increased or decreased levels of this protein. If the level of 
Tdp1 is found to be significantly altered in any of the cancers, then it can serve as a 
useful tool in their detection. This technology also has many potential commercial uses 
including: a method for screening camptothecin analogues or other compounds for their 
resistance to repair by Tdp1 or to prescreen patients for their sensitivity to topisomerase 
inhibitors which could identify patients most likely to respond to camptothecin therapy. 
Further, it also provides for a vector comprising of the nucleic acid molecule for TDP1 as 
well as the method of altering the level of TDP1 in a cell, a tissue, an organ or an 
organism. Another possibility is that cells, particularly neurons wuth lower than normal 
levels of Tdp1 may be more susceptible to oxidative DNA damage. Molecular 
diagnostics may identify individuals with such partial Tdp1 deficiency as candidates for 
anti-oxidant preventive therapies. 
 In conclusion, the identification of Tdp1 adds a new level of complexity to the 
field of DNA DSB repair. Though our data conclusively shows that Tdp1 is capable of 
removing PGs from DNA DSBs, we could not find any proof of its interaction with any 
of the protein machinery of NHEJ repair pathway. Studying the gentypic and phenotypic 
characteristics of tdp1-/- knockout mice in comparison with wild-type mice will unveil 
important information as to the exact role of Tdp1 in repair of free radical mediated DNA 
DSBs. If such a role were determined, it would contribute significantly towards making it 
a prime target for chemotherapy, radiotherapy or a combination of both. 
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